P0907 : Pharmacokinetics, pharmacodynamics, and toxicity profile of RG-101, a novel GalNAc-conjugated hepatocyte-targetng inhibitor of microrna-122, in rodents and cynomolgus monkeys (Englisch)
- Neue Suche nach: Neben, S.
- Neue Suche nach: Liu, K.
- Neue Suche nach: Berman, C.
- Neue Suche nach: Tay, J.
- Neue Suche nach: Esau, C.
- Neue Suche nach: Kaiser, R.
- Neue Suche nach: Wahle, B.
- Neue Suche nach: Chau, N.
- Neue Suche nach: Bhat, B.
- Neue Suche nach: Gibson, N. W.
- Neue Suche nach: Neben, S.
- Neue Suche nach: Liu, K.
- Neue Suche nach: Berman, C.
- Neue Suche nach: Tay, J.
- Neue Suche nach: Esau, C.
- Neue Suche nach: Kaiser, R.
- Neue Suche nach: Wahle, B.
- Neue Suche nach: Chau, N.
- Neue Suche nach: Bhat, B.
- Neue Suche nach: Gibson, N. W.
In:
JOURNAL OF HEPATOLOGY
;
62
;
S684-S685
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:P0907 : Pharmacokinetics, pharmacodynamics, and toxicity profile of RG-101, a novel GalNAc-conjugated hepatocyte-targetng inhibitor of microrna-122, in rodents and cynomolgus monkeys
-
Beteiligte:Neben, S. ( Autor:in ) / Liu, K. ( Autor:in ) / Berman, C. ( Autor:in ) / Tay, J. ( Autor:in ) / Esau, C. ( Autor:in ) / Kaiser, R. ( Autor:in ) / Wahle, B. ( Autor:in ) / Chau, N. ( Autor:in ) / Bhat, B. ( Autor:in ) / Gibson, N. W. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 62 ; S684-S685
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:S684-S685
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 62
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Journal of Hepatology: The home of liver researchJalan, R. et al. | 2015
- 4
-
50 years of EASL – From a European to a global perspectivePeck-Radosavljevic, M. et al. | 2015
- 6
-
From the Editor's Desk ...| 2015
- 8
-
Are statins a remedy for all seasons?Negro, F. et al. | 2015
- 11
-
Absent in melanoma (AIM2) but present in ascitic fluid macrophages from patients with cirrhosisGustot, T. et al. | 2015
- 13
-
Correction of hyponatraemia in cirrhosis: Treating more than a number!Cárdenas, A. s. / Riggio, O. et al. | 2015
- 15
-
NAFLD incidence and remission: Only a matter of weight gain and weight loss?Marchesini, G. / Mazzotti, A. et al. | 2015
- 18
-
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis CSimon, T. G. / King, L. Y. / Zheng, H. / Chung, R. T. et al. | 2015
- 24
-
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitisSaadoun, D. / Resche Rigon, M. / Pol, S. / Thibault, V. / Blanc, F. o. / Pialoux, G. / Karras, A. / Bazin-Kara, D. e. / Cazorla, C. c. / Vittecoq, D. et al. | 2015
- 31
-
A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis COwusu Sekyere, S. / Suneetha, P. V. / Kraft, A. R. / Zhang, S. / Dietz, J. / Sarrazin, C. / Manns, M. P. / Schlaphoff, V. / Cornberg, M. / Wedemeyer, H. et al. | 2015
- 41
-
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyMarcellin, P. / Wursthorn, K. / Wedemeyer, H. / Chuang, W. L. / Lau, G. / Avila, C. / Peng, C. Y. / Gane, E. / Lim, S. G. / Fainboim, H. et al. | 2015
- 48
-
HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patientsLosikoff, P. T. / Mishra, S. / Terry, F. / Gutierrez, A. / Ardito, M. T. / Fast, L. / Nevola, M. / Martin, W. D. / Bailey-Kellogg, C. / De Groot, A. S. et al. | 2015
- 56
-
Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW studyZoulim, F. / Carosi, G. / Greenbloom, S. / Mazur, W. / Nguyen, T. / Jeffers, L. / Brunetto, M. / Yu, S. / Llamoso, C. et al. | 2015
- 64
-
Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosisLozano-Ruiz, B. / Bachiller, V. / García-Martínez, I. / Zapater, P. / Gómez-Hurtado, I. / Moratalla, A. / Giménez, P. / Bellot, P. / Francés, R. n. / Such, J. et al. | 2015
- 72
-
Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosisTuron, F. / Cervantes, F. / Colomer, D. / Baiges, A. / Hernández-Gea, V. / Garcia-Pagán, J. C. et al. | 2015
- 75
-
Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosisAhluwalia, V. / Heuman, D. M. / Feldman, G. / Wade, J. B. / Thacker, L. R. / Gavis, E. / Gilles, H. / Unser, A. / White, M. B. / Bajaj, J. S. et al. | 2015
- 83
-
The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioningJiménez-Castro, M. n. / Meroño, N. / Mendes-Braz, M. / Gracia-Sancho, J. / Martínez-Carreres, L. / Cornide-Petronio, M. E. / Casillas-Ramirez, A. / Rodés, J. / Peralta, C. et al. | 2015
- 92
-
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort studyCastells, L. / Rimola, A. / Manzardo, C. / Valdivieso, A. s. / Montero, J. L. / Barcena, R. / Abradelo, M. / Xiol, X. / Aguilera, V. / Salcedo, M. et al. | 2015
- 101
-
MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cellsMöbus, S. / Yang, D. / Yuan, Q. / Lüdtke, T. H. / Balakrishnan, A. / Sgodda, M. / Rani, B. / Kispert, A. / Araúzo-Bravo, M. J. / Vogel, A. et al. | 2015
- 111
-
Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injuryWang, P. X. / Zhang, R. / Huang, L. / Zhu, L. H. / Jiang, D. S. / Chen, H. Z. / Zhang, Y. / Tian, S. / Zhang, X. F. / Zhang, X. D. et al. | 2015
- 121
-
SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinomaZhang, Z. Y. / Hong, D. / Nam, S. H. / Kim, J. M. / Paik, Y. H. / Joh, J. W. / Kwon, C. H. / Park, J. B. / Choi, G. S. / Jang, K. Y. et al. | 2015
- 131
-
Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinomaLi, X. F. / Chen, D. P. / Ouyang, F. Z. / Chen, M. M. / Wu, Y. / Kuang, D. M. / Zheng, L. et al. | 2015
- 140
-
Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injuryCubero, F. J. / Zhao, G. / Nevzorova, Y. A. / Hatting, M. / Al Masaoudi, M. / Verdier, J. / Peng, J. / Schaefer, F. M. / Hermanns, N. / Boekschoten, M. V. et al. | 2015
- 150
-
Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2cmForner, A. / Vilana, R. n. / Bianchi, L. / Rodríguez-Lope, C. / Reig, M. a. / García-Criado, M. n. / Rimola, J. / Solé, M. / Ayuso, C. / Bru, C. et al. | 2015
- 156
-
S100A4 promotes liver fibrosis via activation of hepatic stellate cellsChen, L. / Li, J. / Zhang, J. / Dai, C. / Liu, X. / Wang, J. / Gao, Z. / Guo, H. / Wang, R. / Lu, S. et al. | 2015
- 165
-
Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cellsTian, W. / Hao, C. / Fan, Z. / Weng, X. / Qin, H. / Wu, X. / Fang, M. / Chen, Q. / Shen, A. / Xu, Y. et al. | 2015
- 175
-
Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesityRabinowich, L. / Fishman, S. / Hubel, E. / Thurm, T. / Park, W. J. / Pewzner-Jung, Y. / Saroha, A. / Erez, N. / Halpern, Z. / Futerman, A. H. et al. | 2015
- 182
-
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopyWong, V. W. / Wong, G. L. / Yeung, D. K. / Lau, T. K. / Chan, C. K. / Chim, A. M. / Abrigo, J. M. / Chan, R. S. / Woo, J. / Tse, Y. K. et al. | 2015
- 190
-
Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trialArgo, C. K. / Patrie, J. T. / Lackner, C. / Henry, T. D. / de Lange, E. E. / Weltman, A. L. / Shah, N. L. / Al-Osaimi, A. M. / Pramoonjago, P. / Jayakumar, S. et al. | 2015
- 198
-
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological conceptsRaggi, C. / Invernizzi, P. / Andersen, J. B. et al. | 2015
- 208
-
Unmet clinical need in autoimmune liver diseasesDyson, J. K. / Webb, G. / Hirschfield, G. M. / Lohse, A. / Beuers, U. / Lindor, K. / Jones, D. E. et al. | 2015
- 219
-
Acid sphingomyelinase-ceramide system in steatohepatitis: A novel target regulating multiple pathwaysGarcia-Ruiz, C. / Mato, J. M. / Vance, D. / Kaplowitz, N. / Fernández-Checa, J. C. et al. | 2015
- 234
-
Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case reportRossotti, R. / Travi, G. / Pazzi, A. / Baiguera, C. / Morra, E. / Puoti, M. et al. | 2015
- 238
-
A response-guided approach based on HBsAg kinetics may identify patients with the greatest chance of successHalfon, P. / Pénaranda, G. / Ouzan, D. et al. | 2015
- 239
-
HBeAg-positive chronic hepatitis B patients with prior long-time exposure to nucleos(t)ide analogues: “Switch-to” or “add-on” PegIFN alfa, that is the questionChen, S. / Zhang, W. et al. | 2015
- 240
-
An integration of deep viral suppression with sequential immune modulation (cocktail therapy) to restore antiviral capacity: The future of chronic hepatitis B?Wu, D. / Han, M. / Ning, Q. et al. | 2015
- 241
-
ALPPS procedure for hepatocellular carcinoma with macrovascular thrombosis: A new opportunity?Levi Sandri, G. B. / Lai, Q. / Rayar, M. / Sulpice, L. et al. | 2015
- 243
-
Reply to: “ALPPS procedure for hepatocellular carcinoma with macrovascular thrombosis: A new opportunity?”Kokudo, T. / Hasegawa, K. / Kokudo, N. et al. | 2015
- 243
-
Chronic kidney disease after liver transplantationLeithead, J. A. / Ferguson, J. W. et al. | 2015
- 244
-
Reply to: “Chronic kidney disease after liver transplantation”Allen, A. M. / Kim, W. R. / Therneau, T. M. / Larson, J. J. / Heimbach, J. K. / Rule, A. D. et al. | 2015
- 245
-
Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?Cai, J. / Guo, W. / He, C. / Han, G. et al. | 2015
- 247
-
Reply to: “Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?”Nicolas, C. / d’Alteroche, L. / Perarnau, J. M. et al. | 2015
- 248
-
A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infectionBroccolo, F. / Ciccarese, G. / Picciotto, A. / Drago, F. et al. | 2015
- 250
-
The reporting of animal welfare details in liver research: A review of studies describing bile duct ligation in mice (2011–2013)Secklehner, J. / Richardson, C. A. et al. | 2015
- 253
-
From the Editor’s Desk Feb 2015| 2015
- 255
-
A Multi-Journal Partnership to Highlight Joint First-Authors of ManuscriptsOmary, M. B. / Wallace, M. B. / El-Omar, E. M. / Jalan, R. / Nathanson, M. H. et al. | 2015
- 257
-
Molecularly targeted therapies for human hepatocellular carcinoma: Should we start from β-catenin inhibition?Calvisi, D. F. et al. | 2015
- 260
-
Arginine and NASH – Do macrophages deliver the first hit?Scheja, L. / Kluwe, J. et al. | 2015
- 262
-
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?McDonald, S. A. / Innes, H. A. / Hayes, P. C. / Dillon, J. F. / Mills, P. R. / Goldberg, D. J. / Barclay, S. / Allen, S. / Fox, R. / Fraser, A. et al. | 2015
- 269
-
Trends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatmentAspinall, E. J. / Hutchinson, S. J. / Janjua, N. Z. / Grebely, J. / Yu, A. / Alavi, M. / Amin, J. / Goldberg, D. J. / Innes, H. / Law, M. et al. | 2015
- 278
-
Hepatitis C viral proteins perturb metabolic liver zonationMoreau, M. / Rivière, B. / Vegna, S. / Aoun, M. / Gard, C. / Ramos, J. / Assenat, E. / Hibner, U. et al. | 2015
- 286
-
Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGETGordon, S. C. / Muir, A. J. / Lim, J. K. / Pearlman, B. / Argo, C. K. / Ramani, A. / Maliakkal, B. / Alam, I. / Stewart, T. G. / Vainorius, M. et al. | 2015
- 294
-
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirinFeld, J. J. / Jacobson, I. M. / Jensen, D. M. / Foster, G. R. / Pol, S. / Tam, E. / Jablkowski, M. / Berak, H. / Vierling, J. M. / Yoshida, E. M. et al. | 2015
- 303
-
CD4+CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responsesSpaan, M. / Kreefft, K. / de Graav, G. N. / Brouwer, W. P. / de Knegt, R. J. / ten Kate, F. J. / Baan, C. C. / Vanwolleghem, T. / Janssen, H. L. / Boonstra, A. et al. | 2015
- 311
-
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosisLondoño, M. C. / Perelló, C. / Cabezas, J. n. / Cañete, N. / Lens, S. / Mariño, Z. / Gambato, M. / Rodríguez, R. / Menéndez, S. / Carrión, J. A. et al. | 2015
- 317
-
Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastographyDeffieux, T. / Gennisson, J. L. / Bousquet, L. / Corouge, M. / Cosconea, S. / Amroun, D. / Tripon, S. / Terris, B. / Mallet, V. / Sogni, P. et al. | 2015
- 325
-
Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertensionMookerjee, R. P. / Mehta, G. / Balasubramaniyan, V. / Mohamed, F. E. / Davies, N. / Sharma, V. / Iwakiri, Y. / Jalan, R. et al. | 2015
- 332
-
CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shuntBerres, M. L. / Asmacher, S. / Lehmann, J. / Jansen, C. / Görtzen, J. / Klein, S. / Meyer, C. / Strunk, H. M. / Fimmers, R. / Tacke, F. et al. | 2015
- 340
-
Incidence and impact of rejection following simultaneous liver-kidney transplantationNilles, K. M. / Krupp, J. / Lapin, B. / Sustento-Reodica, N. / Gallon, L. / Levitsky, J. et al. | 2015
- 346
-
Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL)Ladner, D. P. / Dew, M. A. / Forney, S. / Gillespie, B. W. / Brown, R. S. / Merion, R. M. / Freise, C. E. / Hayashi, P. H. / Hong, J. C. / Ashworth, A. et al. | 2015
- 354
-
C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitisLiu, J. / Tan, Y. / Zhang, J. / Zou, L. / Deng, G. / Xu, X. / Wang, F. / Ma, Z. / Zhao, T. et al. | 2015
- 363
-
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovirPapatheodoridis, G. V. / Dalekos, G. N. / Yurdaydin, C. / Buti, M. / Goulis, J. / Arends, P. / Sypsa, V. / Manolakopoulos, S. / Mangia, G. / Gatselis, N. et al. | 2015
- 371
-
TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in miceJiang, S. / Minter, L. C. / Stratton, S. A. / Yang, P. / Abbas, H. A. / Akdemir, Z. C. / Pant, V. / Post, S. / Gagea, M. / Lee, R. G. et al. | 2015
- 380
-
Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis modelDelgado, E. / Okabe, H. / Preziosi, M. / Russell, J. O. / Alvarado, T. F. / Oertel, M. / Nejak-Bowen, K. N. / Zhang, Y. / Monga, S. P. et al. | 2015
- 388
-
Alcohol directly stimulates epigenetic modifications in hepatic stellate cellsPage, A. / Paoli, P. P. / Hill, S. J. / Howarth, R. / Wu, R. / Kweon, S. M. / French, J. / White, S. / Tsukamoto, H. / Mann, D. A. et al. | 2015
- 398
-
Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell typeLanghans, B. / Alwan, A. W. / Krämer, B. / Glässner, A. / Lutz, P. / Strassburg, C. P. / Nattermann, J. / Spengler, U. et al. | 2015
- 405
-
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitisBril, F. / Maximos, M. / Portillo-Sanchez, P. / Biernacki, D. / Lomonaco, R. / Subbarayan, S. / Correa, M. / Lo, M. / Suman, A. / Cusi, K. et al. | 2015
- 412
-
Arginase 2 deficiency results in spontaneous steatohepatitis: A novel link between innate immune activation and hepatic de novo lipogenesisNavarro, L. A. / Wree, A. / Povero, D. / Berk, M. P. / Eguchi, A. / Ghosh, S. / Papouchado, B. G. / Erzurum, S. C. / Feldstein, A. E. et al. | 2015
- 421
-
Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in micePeyrou, M. / Bourgoin, L. / Poher, A. L. / Altirriba, J. / Maeder, C. / Caillon, A. l. / Fournier, M. / Montet, X. / Rohner-Jeanrenaud, F. o. / Foti, M. et al. | 2015
- 430
-
Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr−/− miceHendrikx, T. / Jeurissen, M. L. / Bieghs, V. / Walenbergh, S. M. / van Gorp, P. J. / Verheyen, F. / Houben, T. / Guichot, Y. D. / Gijbels, M. J. / Leitersdorf, E. et al. | 2015
- 437
-
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failureRomero-Gómez, M. / Montagnese, S. / Jalan, R. et al. | 2015
- 448
-
miR-122 – A key factor and therapeutic target in liver diseaseBandiera, S. / Pfeffer, S. b. / Baumert, T. F. / Zeisel, M. B. et al. | 2015
- 458
-
The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver – A systematic reviewStrauss, O. / Dunbar, P. R. / Bartlett, A. / Phillips, A. et al. | 2015
- 469
-
Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approachLemoine, M. / Eholié, S. / Lacombe, K. et al. | 2015
- 477
-
Reports from the International Liver Cancer Association (ILCA) congress 2014Nault, J. C. et al. | 2015
- 483
-
Familial amyloidosis: Great progress for an orphan diseaseBarreiros, A. P. / Otto, G. / Kahlen, B. / Teufel, A. / Galle, P. R. et al. | 2015
- 486
-
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patientQasim, W. / Brunetto, M. / Gehring, A. J. / Xue, S. A. / Schurich, A. / Khakpoor, A. / Zhan, H. / Ciccorossi, P. / Gilmour, K. / Cavallone, D. et al. | 2015
- 492
-
Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohortAdhoute, X. / Penaranda, G. / Bronowicki, J. P. / Raoul, J. L. et al. | 2015
- 493
-
Transient increase in urine protein excretion during treatment with terlipressin and albumin for type-1 hepatorenal syndromeElia, C. / Solà Vergés, E. / Rodríguez, E. / Ginès, P. et al. | 2015
- 495
-
Deficiency of periostin protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitisLi, Y. / Wu, S. / Xiong, S. / Ouyang, G. et al. | 2015
- 497
-
TERT promoter mutation during development of hepatoblastoma to hepatocellular carcinomaDong, R. / Zheng, S. / Dong, K. et al. | 2015
- 498
-
Reply to: “TERT promoter mutation during development of hepatoblastoma to hepatocellular carcinoma”Kappler, R. / Leuschner, I. / von Schweinitz, D. et al. | 2015
- 499
-
Ferritin in decompensated cirrhosis: Iron or inflammation?Ryan, J. D. / Chin, J. L. / Crowe, J. et al. | 2015
- 500
-
Reply to: “Ferritin in decompensated cirrhosis: Iron or inflammation?”Maiwall, R. / Maras, J. S. / Kumar, S. / Sarin, S. K. et al. | 2015
- 503
-
From the Editor’s Desk… March 2015| 2015
- 505
-
Do we need more nucleos(t)ide analogs for the treatment of chronic hepatitis B?Petersen, J. et al. | 2015
- 508
-
Prognostic value of skin perfusion alterations in cirrhotic patients with septic shockFernández, J. et al. | 2015
- 510
-
Should C282Y homozygotes with mild iron overload be treated?Zoller, H. / Finkenstedt, A. et al. | 2015
- 512
-
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infectionHuang, C. F. / Dai, C. Y. / Yeh, M. L. / Huang, C. I. / Tai, C. M. / Hsieh, M. H. / Liang, P. C. / Lin, Y. H. / Hsieh, M. Y. / Yang, H. L. et al. | 2015
- 519
-
Hepatitis C virus infection increases the risk of developing peripheral arterial disease: A 9-year population-based cohort studyHsu, Y. H. / Muo, C. H. / Liu, C. Y. / Tsai, W. C. / Hsu, C. C. / Sung, F. C. / Kao, C. H. et al. | 2015
- 526
-
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre studyYuen, M. F. / Ahn, S. H. / Lee, K. S. / Um, S. H. / Cho, M. / Yoon, S. K. / Lee, J. W. / Park, N. H. / Kweon, Y. O. / Sohn, J. H. et al. | 2015
- 533
-
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infectionAgarwal, K. / Fung, S. K. / Nguyen, T. T. / Cheng, W. / Sicard, E. / Ryder, S. D. / Flaherty, J. F. / Lawson, E. / Zhao, S. / Subramanian, G. M. et al. | 2015
- 541
-
Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entryLin, L. T. / Chung, C. Y. / Hsu, W. C. / Chang, S. P. / Hung, T. C. / Shields, J. / Russell, R. S. / Lin, C. C. / Li, C. F. / Yen, M. H. et al. | 2015
- 549
-
Exploration of skin perfusion in cirrhotic patients with septic shockGalbois, A. / Bigé, N. k. / Pichereau, C. / Boëlle, P. Y. / Baudel, J. L. / Bourcier, S. / Maury, E. / Guidet, B. / Ait-Oufella, H. et al. | 2015
- 556
-
Microsteatosis may not interact with macrosteatosis in living donor liver transplantationHan, S. / Ha, S. Y. / Park, C. K. / Joh, J. W. / Kwon, C. H. / Kwon, G. Y. / Kim, G. / Gwak, M. S. / Jeong, W. K. / Ko, J. S. et al. | 2015
- 563
-
Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injuryLiu, Y. / Ji, H. / Zhang, Y. / Shen, X. / Gao, F. / He, X. / Li, G. A. / Busuttil, R. W. / Kuchroo, V. K. / Kupiec-Weglinski, J. W. et al. | 2015
- 573
-
Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulationMandili, G. / Alchera, E. / Merlin, S. / Imarisio, C. / Chandrashekar, B. R. / Riganti, C. / Bianchi, A. / Novelli, F. / Follenzi, A. / Carini, R. et al. | 2015
- 581
-
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytesBaxter, M. / Withey, S. / Harrison, S. / Segeritz, C. P. / Zhang, F. / Atkinson-Dell, R. / Rowe, C. / Gerrard, D. T. / Sison-Young, R. / Jenkins, R. et al. | 2015
- 590
-
Role for the endoplasmic reticulum stress sensor IRE1α in liver regenerative responsesLiu, Y. / Shao, M. / Wu, Y. / Yan, C. / Jiang, S. / Liu, J. / Dai, J. / Yang, L. / Li, J. / Jia, W. et al. | 2015
- 599
-
Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamineHealy, M. E. / Chow, J. D. / Byrne, F. L. / Breen, D. S. / Leitinger, N. / Li, C. / Lackner, C. / Caldwell, S. H. / Hoehn, K. L. et al. | 2015
- 607
-
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinomaYeung, O. W. / Lo, C. M. / Ling, C. C. / Qi, X. / Geng, W. / Li, C. X. / Ng, K. T. / Forbes, S. J. / Guan, X. Y. / Poon, R. T. et al. | 2015
- 617
-
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre studyVitale, A. / Burra, P. / Frigo, A. C. / Trevisani, F. / Farinati, F. / Spolverato, G. / Volk, M. / Giannini, E. G. / Ciccarese, F. / Piscaglia, F. et al. | 2015
- 625
-
Inhibition of fibronectin deposition improves experimental liver fibrosisAltrock, E. / Sens, C. / Wuerfel, C. / Vasel, M. / Kawelke, N. / Dooley, S. / Sottile, J. / Nakchbandi, I. A. et al. | 2015
- 634
-
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in miceMeier, R. P. / Mahou, R. / Morel, P. / Meyer, J. / Montanari, E. / Muller, Y. D. / Christofilopoulos, P. / Wandrey, C. / Gonelle-Gispert, C. / Bühler, L. H. et al. | 2015
- 642
-
Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitisHartl, J. / Ehlken, H. / Weiler-Normann, C. / Sebode, M. / Kreuels, B. / Pannicke, N. / Zenouzi, R. / Glaubke, C. / Lohse, A. W. / Schramm, C. et al. | 2015
- 647
-
Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagyGuo, R. / Xu, X. / Babcock, S. A. / Zhang, Y. / Ren, J. et al. | 2015
- 657
-
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2Zhou, Y. / Llauradó, G. / Orešič, M. / Hyötyläinen, T. / Orho-Melander, M. / Yki-Järvinen, H. et al. | 2015
- 664
-
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosisde Tayrac, M. / Roth, M. P. / Jouanolle, A. M. / Coppin, H. l. / le Gac, G. r. / Piperno, A. / Férec, C. / Pelucchi, S. / Scotet, V. / Bardou-Jacquet, E. et al. | 2015
- 673
-
S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver diseaseMartínez-Uña, M. / Varela-Rey, M. / Mestre, D. / Fernández-Ares, L. / Fresnedo, O. / Fernandez-Ramos, D. / Juan, V. G. / Martin-Guerrero, I. / García-Orad, A. / Luka, Z. et al. | 2015
- 682
-
Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosisBardou-Jacquet, E. / Morcet, J. / Manet, G. / Lainé, F. / Perrin, M. l. / Jouanolle, A. M. / Guyader, D. / Moirand, R. / Viel, J. F. / Deugnier, Y. et al. | 2015
- 690
-
New imaging techniques for liver diseasesVan Beers, B. E. / Daire, J. L. / Garteiser, P. et al. | 2015
- 701
-
Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 updateMiro, J. M. / Stock, P. / Teicher, E. / Duclos-Vallée, J. C. / Terrault, N. / Rimola, A. et al. | 2015
- 712
-
Bioinformatics and database resources in hepatologyTeufel, A. et al. | 2015
- 720
-
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver diseasePawlak, M. / Lefebvre, P. / Staels, B. et al. | 2015
- 734
-
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyriasSchneider-Yin, X. / van Tuyll van Serooskerken, A. M. / Siegesmund, M. / Went, P. / Barman-Aksözen, J. / Bladergroen, R. S. / Komminoth, P. / Cloots, R. H. / Winnepenninckx, V. r. / zur Hausen, A. et al. | 2015
- 739
-
The rescue of DCD rodent livers grafts: Is there HOPE?Kopp, W. H. / Wijermars, L. G. / Ringers, J. / Braat, A. E. et al. | 2015
- 739
-
Reply to: “The rescue of DCD rodent livers grafts: Is there HOPE?”Schlegel, A. / Dutkowski, P. / Clavien, P. A. et al. | 2015
- 741
-
A cut-off serum creatinine value of 1.5mg/dl for AKI – To be or not to beWong, F. / O’Leary, J. G. / Reddy, K. R. / Kamath, P. S. / Garcia-Tsao, G. / Maliakkal, B. / Subramanian, R. / Thacker, L. / Bajaj, J. et al. | 2015
- 743
-
Reply to: “A cut-off serum creatinine value of 1.5mg/dl for AKI – To be or not to be”Fagundes, C. / Barreto, R. / Rodríguez, E. / Graupera, I. / Poch, E. / Solà, E. / Fernández, J. / Ginès, P. et al. | 2015
- 746
-
Interaction between infection and hepatic encephalopathyMerli, M. / Riggio, O. et al. | 2015
- 747
-
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCTMetussin, A. / Patanwala, I. / Cross, T. J. et al. | 2015
- 748
-
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: A randomized controlled trialPang, Q. / Liu, C. / Zhang, J. Y. / Xu, X. S. et al. | 2015
- 750
-
Target patients for partial hepatectomy and relationship between PLT and prognosis in BCLC B HCCLei, Y. / Yee, L. W. / Ping, Z. W. et al. | 2015
- 751
-
Acute liver failure following atorvastatin dose escalation: Is there a threshold dose for idiosyncratic hepatotoxicity?Carrascosa, M. F. / Salcines-Caviedes, J. R. / Lucena, M. I. / Andrade, R. J. et al. | 2015
- 753
-
From the Editor’s Desk… April 2015| 2015
- 756
-
Going full circle: Validation of P-body dispersion in hepatitis C virus-infected patientsRuggieri, A. / Bartenschlager, R. et al. | 2015
- 759
-
Corticosteroids can be used to treat alcoholic hepatitis after a recent upper gastrointestinal bleedMorgan, T. R. et al. | 2015
- 761
-
Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?Birerdinc, A. / Younossi, Z. et al. | 2015
- 763
-
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolismBridge, S. H. / Sheridan, D. A. / Felmlee, D. J. / Crossey, M. M. / Fenwick, F. I. / Lanyon, C. V. / Dubuc, G. v. / Seidah, N. G. / Davignon, J. / Thomas, H. C. et al. | 2015
- 771
-
MDA5 plays a critical role in interferon response during hepatitis C virus infectionCao, X. / Ding, Q. / Lu, J. / Tao, W. / Huang, B. / Zhao, Y. / Niu, J. / Liu, Y. J. / Zhong, J. et al. | 2015
- 779
-
Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavageWelsch, C. / Haselow, K. / Gouttenoire, J. r. / Schneider, M. / Morikawa, K. / Martinez, Y. / Susser, S. / Sarrazin, C. / Zeuzem, S. / Antes, I. et al. | 2015
- 785
-
Hepatitis C virus infection inhibits P-body granule formation in human liversPérez-Vilaró, G. / Fernández-Carrillo, C. / Mensa, L. / Miquel, R. / Sanjuan, X. / Forns, X. / Pérez-del-Pulgar, S. a. / DÃÂez, J. et al. | 2015
- 791
-
Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI levelPeiffer, K. H. / Akhras, S. / Himmelsbach, K. / Hassemer, M. / Finkernagel, M. / Carra, G. / Nuebling, M. / Chudy, M. / Niekamp, H. / Glebe, D. et al. | 2015
- 799
-
Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failureGarcia-Martinez, R. / Andreola, F. / Mehta, G. / Poulton, K. / Oria, M. / Jover, M. / Soeda, J. / Macnaughtan, J. / De Chiara, F. / Habtesion, A. et al. | 2015
- 807
-
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standardsBoursier, J. r. / de Ledinghen, V. / Poynard, T. / Guéchot, J. r. / Carrat, F. / Leroy, V. / Wong, G. L. / Friedrich-Rust, M. / Fraquelli, M. / Plebani, M. et al. | 2015
- 816
-
Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleedingRudler, M. / Mouri, S. / Charlotte, F. d. / Lebray, P. / Capocci, R. / Benosman, H. / Poynard, T. / Thabut, D. et al. | 2015
- 822
-
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trialThévenot, T. / Bureau, C. / Oberti, F. d. / Anty, R. / Louvet, A. / Plessier, A. l. / Rudler, M. / Heurgué-Berlot, A. / Rosa, I. / Talbodec, N. et al. | 2015
- 831
-
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failureJalan, R. / Pavesi, M. / Saliba, F. / Amorós, A. / Fernandez, J. / Holland-Fischer, P. / Sawhney, R. / Mookerjee, R. / Caraceni, P. / Moreau, R. et al. | 2015
- 841
-
The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart diseaseLazo, M. / Rubin, J. / Clark, J. M. / Coresh, J. / Schneider, A. L. / Ndumele, C. / Hoogeveen, R. C. / Ballantyne, C. M. / Selvin, E. et al. | 2015
- 848
-
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasionPoté, N. / Cauchy, F. o. / Albuquerque, M. / Voitot, H. l. / Belghiti, J. / Castera, L. / Puy, H. / Bedossa, P. / Paradis, V. r. et al. | 2015
- 855
-
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making processAdhoute, X. / Penaranda, G. / Naude, S. / Raoul, J. L. / Perrier, H. / Bayle, O. / Monnet, O. / Beaurain, P. / Bazin, C. / Pol, B. et al. | 2015
- 863
-
Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretionSprinzl, M. F. / Puschnik, A. / Schlitter, A. M. / Schad, A. / Ackermann, K. / Esposito, I. / Lang, H. / Galle, P. R. / Weinmann, A. / Heikenwälder, M. et al. | 2015
- 871
-
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasisSombetzki, M. / Fuchs, C. D. / Fickert, P. / Österreicher, C. H. / Mueller, M. / Claudel, T. / Loebermann, M. / Engelmann, R. / Langner, C. / Sahin, E. et al. | 2015
- 879
-
Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesisRachidi, S. / Sun, S. / Wu, B. X. / Jones, E. / Drake, R. R. / Ogretmen, B. / Cowart, L. A. / Clarke, C. J. / Hannun, Y. A. / Chiosis, G. et al. | 2015
- 889
-
Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signallingXiao, Y. / Wang, J. / Yan, W. / Zhou, Y. / Chen, Y. / Zhou, K. / Wen, J. / Wang, Y. / Cai, W. et al. | 2015
- 897
-
Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancyKremer, A. E. / Bolier, R. / Dixon, P. H. / Geenes, V. / Chambers, J. / Tolenaars, D. / Ris-Stalpers, C. / Kaess, B. M. / Rust, C. / van der Post, J. A. et al. | 2015
- 905
-
Circulating phospholipid profiling identifies portal contribution to NASH signature in obesityAnjani, K. / Lhomme, M. / Sokolovska, N. / Poitou, C. / Aron-Wisnewsky, J. / Bouillot, J. L. / Lesnik, P. / Bedossa, P. / Kontush, A. / Clement, K. et al. | 2015
- 913
-
Vagus nerve contributes to the development of steatohepatitis and obesity in phosphatidylethanolamine N-methyltransferase deficient miceGao, X. / van der Veen, J. N. / Zhu, L. / Chaba, T. / Ordoñez, M. / Lingrell, S. / Koonen, D. P. / Dyck, J. R. / Gomez-Muñoz, A. / Vance, D. E. et al. | 2015
- 921
-
Roles of alcohol consumption in fatty liver: A longitudinal studyMoriya, A. / Iwasaki, Y. / Ohguchi, S. / Kayashima, E. / Mitsumune, T. / Taniguchi, H. / Ando, M. / Yamamoto, K. et al. | 2015
- 928
-
Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver diseasePetta, S. / Argano, C. / Colomba, D. / Cammà, C. / Di Marco, V. / Cabibi, D. / Tuttolomondo, A. / Marchesini, G. / Pinto, A. / Licata, G. et al. | 2015
- 934
-
Autophagy and senescence in fibrosing cholangiopathiesNakanuma, Y. / Sasaki, M. / Harada, K. et al. | 2015
- 946
-
Outcomes in liver transplantation: Does sex matter?Sarkar, M. / Watt, K. D. / Terrault, N. / Berenguer, M. et al. | 2015
- 956
-
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapyPapatheodoridis, G. V. / Chan, H. L. / Hansen, B. E. / Janssen, H. L. / Lampertico, P. et al. | 2015
- 968
-
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of AscitesAngeli, P. / Ginès, P. / Wong, F. / Bernardi, M. / Boyer, T. D. / Gerbes, A. / Moreau, R. / Jalan, R. / Sarin, S. K. / Piano, S. et al. | 2015
- 975
-
Solutions to the discrepancies in the extent of liver damage following ischemia/reperfusion in standard mouse modelsvan Golen, R. F. / Reiniers, M. J. / Heger, M. / Verheij, J. et al. | 2015
- 977
-
Hepatic hepcidin expression is decreased in cirrhosis and HCCKessler, S. M. / Laggai, S. / Kiemer, A. K. / Barghash, A. / Helms, V. et al. | 2015
- 979
-
Reply to: “Hepatic hepcidin expression is decreased in cirrhosis and HCC�Lunova, M. / Trautwein, C. / Strnad, P. / Nahon, P. et al. | 2015
- 980
-
HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritanceKrawczyk, M. / Stokes, C. S. / Romeo, S. / Lammert, F. et al. | 2015
- 982
-
Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritanceAnstee, Q. M. / Liu, Y. L. / Day, C. P. / Reeves, H. L. et al. | 2015
- 983
-
Chronic kidney disease (CKD) and NAFLD: Time for awareness and screeningMusso, G. / Tabibian, J. H. / Charlton, M. et al. | 2015
- 984
-
Reply to: “Chronic kidney disease (CKD) and NAFLD: Time for awareness and screening�Allen, A. M. / Kim, W. R. / Heimbach, J. K. / Rule, A. D. et al. | 2015
- 985
-
A scoring system for biliary atresia: Is this the right one?Sciveres, M. / Milazzo, M. P. / Maggiore, G. et al. | 2015
- 986
-
Reply to: “A scoring system for biliary atresia: Is this the right one?�El-Guindi, M. A. / Sira, M. M. / Sira, A. M. / Salem, T. A. et al. | 2015
- 988
-
Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) – Use of the Delphi technique for content validationTrevisol, D. J. / da Silva, A. / de Souza, F. c. / Zapelini, C. v. et al. | 2015
- 989
-
Reply to: “Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) – Use of the Delphi technique for content validation�Temmerman, F. / Nevens, F. et al. | 2015
- 991
-
From the Editor’s desk…:May 2015Moreau, R. / Bataller, R. / Berg, T. / Zucman-Rossi, J. / Jalan, R. et al. | 2015
- 995
-
Jean-Claude Trinchet (1951-2014)Beaugrand, M. et al. | 2015
- 996
-
Optimism for patients with genotype 4 HCV infection: Clinical trials with direct-acting antivirals finally availableAsselah, T. et al. | 2015
- 1000
-
Patterns of drinking and liver cirrhosis – What do we know and where do we go?Rehm, J. r. / Roerecke, M. et al. | 2015
- 1002
-
Non-alcoholic fatty liver – Perhaps not so benignAdams, L. A. / Ratziu, V. et al. | 2015
- 1005
-
Pituitary TSH controls bile salt synthesisJansen, P. L. / Schaap, F. G. et al. | 2015
- 1008
-
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studiesLenz, O. / Verbinnen, T. / Fevery, B. / Tambuyzer, L. / Vijgen, L. / Peeters, M. / Buelens, A. / Ceulemans, H. / Beumont, M. / Picchio, G. et al. | 2015
- 1015
-
Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathwaysLiu, S. / Peng, N. / Xie, J. / Hao, Q. / Zhang, M. / Zhang, Y. / Xia, Z. / Xu, G. / Zhao, F. / Wang, Q. et al. | 2015
- 1024
-
The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicingLin, W. / Zhu, C. / Hong, J. / Zhao, L. / Jilg, N. / Fusco, D. N. / Schaefer, E. A. / Brisac, C. / Liu, X. / Peng, L. F. et al. | 2015
- 1033
-
Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarateCharuworn, P. / Hengen, P. N. / Aguilar Schall, R. / Dinh, P. / Ge, D. / Corsa, A. / Reesink, H. W. / Zoulim, F. / Kitrinos, K. M. et al. | 2015
- 1040
-
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestryRuane, P. J. / Ain, D. / Stryker, R. / Meshrekey, R. / Soliman, M. / Wolfe, P. R. / Riad, J. / Mikhail, S. / Kersey, K. / Jiang, D. et al. | 2015
- 1047
-
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4Moreno, C. / Hezode, C. / Marcellin, P. / Bourgeois, S. / Francque, S. / Samuel, D. / Zoulim, F. / Grange, J. D. / Shukla, U. / Lenz, O. et al. | 2015
- 1056
-
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective studyTerg, R. n. / Casciato, P. / Garbe, C. / Cartier, M. / Stieben, T. / Mendizabal, M. / Niveyro, C. / Benavides, J. / Marino, M. n. / Colombato, L. et al. | 2015
- 1061
-
Alcohol drinking pattern and risk of alcoholic liver cirrhosis: A prospective cohort studyAskgaard, G. / Grønbæk, M. / Kjær, M. S. / Tjønneland, A. / Tolstrup, J. S. et al. | 2015
- 1068
-
Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertensionProcopet, B. / Berzigotti, A. / Abraldes, J. G. / Turon, F. / Hernandez-Gea, V. / GarcÃÂa-Pagán, J. C. / Bosch, J. et al. | 2015
- 1076
-
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolizationKim, H. D. / Shim, J. H. / Kim, G. A. / Shin, Y. M. / Yu, E. / Lee, S. G. / Lee, D. / Kim, K. M. / Lim, Y. S. / Lee, H. C. et al. | 2015
- 1085
-
Prenatal acetaminophen induces liver toxicity in dams, reduces fetal liver stem cells, and increases airway inflammation in adult offspringKarimi, K. / Keßler, T. / Thiele, K. / Ramisch, K. / Erhardt, A. / Huebener, P. / Barikbin, R. / Arck, P. / Tiegs, G. et al. | 2015
- 1092
-
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillanceKim, G. A. / Lee, H. C. / Kim, M. J. / Ha, Y. / Park, E. J. / An, J. / Lee, D. / Shim, J. H. / Kim, K. M. / Lim, Y. S. et al. | 2015
- 1100
-
A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patientsFeng, H. / Yu, Z. / Tian, Y. / Lee, Y. Y. / Li, M. S. / Go, M. Y. / Cheung, Y. S. / Lai, P. B. / Chan, A. M. / To, K. F. et al. | 2015
- 1112
-
Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factorsSohn, W. / Paik, Y. H. / Cho, J. Y. / Lim, H. Y. / Ahn, J. M. / Sinn, D. H. / Gwak, G. Y. / Choi, M. S. / Lee, J. H. / Koh, K. C. et al. | 2015
- 1122
-
Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: Risk of HCC recurrence after radiofrequency ablationLee, D. H. / Lee, J. M. / Lee, J. Y. / Kim, S. H. / Kim, J. H. / Yoon, J. H. / Kim, Y. J. / Lee, J. H. / Yu, S. J. / Han, J. K. et al. | 2015
- 1131
-
Liver resection for hepatocellular carcinoma in 313 Western patients: Tumor biology and underlying liver rather than tumor size drive prognosisKluger, M. D. / Salceda, J. A. / Laurent, A. / Tayar, C. / Duvoux, C. / Decaens, T. / Luciani, A. / Van Nhieu, J. T. / Azoulay, D. / Cherqui, D. et al. | 2015
- 1141
-
Use of mouse liver mesothelial cells to prevent postoperative adhesion and promote liver regeneration after hepatectomyInagaki, N. F. / Inagaki, F. F. / Kokudo, N. / Miyajima, A. et al. | 2015
- 1148
-
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical managementMcPherson, S. / Hardy, T. / Henderson, E. / Burt, A. D. / Day, C. P. / Anstee, Q. M. et al. | 2015
- 1156
-
TRAIL receptor deletion in mice suppresses the inflammation of nutrient excessIdrissova, L. / Malhi, H. / Werneburg, N. W. / LeBrasseur, N. K. / Bronk, S. F. / Fingas, C. / Tchkonia, T. / Pirtskhalava, T. / White, T. A. / Stout, M. B. et al. | 2015
- 1164
-
Age at menarche and non-alcoholic fatty liver diseaseRyu, S. / Chang, Y. / Choi, Y. / Kwon, M. J. / Kim, C. W. / Yun, K. E. / Jung, H. S. / Kim, B. K. / Kim, Y. J. / Ahn, J. et al. | 2015
- 1171
-
Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axisSong, Y. / Xu, C. / Shao, S. / Liu, J. / Xing, W. / Xu, J. / Qin, C. / Li, C. / Hu, B. / Yi, S. et al. | 2015
- 1180
-
Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE∗3Leiden miceMorrison, M. C. / Liang, W. / Mulder, P. / Verschuren, L. / Pieterman, E. / Toet, K. / Heeringa, P. / Wielinga, P. Y. / Kooistra, T. / Kleemann, R. et al. | 2015
- 1187
-
Transarterial chemoembolization: Modalities, indication, and patient selectionSieghart, W. / Hucke, F. / Peck-Radosavljevic, M. et al. | 2015
- 1196
-
Clinical trial watch: Reports from the AASLD Liver Meeting®, Boston, November 2014Londoño, M. a. / Abraldes, J. G. / Altamirano, J. / Decaens, T. / Forns, X. et al. | 2015
- 1204
-
A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infectionHassanein, T. / Sims, K. D. / Bennett, M. / Gitlin, N. / Lawitz, E. / Nguyen, T. / Webster, L. / Younossi, Z. / Schwartz, H. / Thuluvath, P. J. et al. | 2015
- 1207
-
Arginase 1: A potential marker of a common pattern of liver steatosis in HCV and NAFLD childrenAlisi, A. / Comparcola, D. / De Stefanis, C. / Nobili, V. et al. | 2015
- 1208
-
Reply to: “Arginase 1: a potential marker of a common pattern of liver steatosis in HCV and NAFLD children�Assenat, E. / Akkari, L. / Moreau, M. / Hibner, U. et al. | 2015
- 1209
-
Protective effects of moderate alcohol consumption on fatty liver: A spurious association?Bell, S. / Britton, A. et al. | 2015
- 1211
-
Reply to: “Protective effects of moderate alcohol consumption on fatty liver: A spurious association?�Moriya, A. / Iwasaki, Y. / Ohguchi, S. / Yamamoto, K. et al. | 2015
- 1212
-
Non-alcoholic fatty liver disease: Severity of fibrosis and its relationships with clinical and biological variablesCorrao, S. / Rinollo, C. / Scaglione, R. et al. | 2015
- 1214
-
Epicardial fat and liver disease; the contribution of cardio autonomic nervous system functionUlucan, S. / Katlandur, H. / Kaya, Z. et al. | 2015
- 1215
-
Epicardial fat in patients with non-alcoholic fatty liver diseasePetta, S. / Craxì, A. et al. | 2015
- 1216
-
Hyperammonemia in ICU patients: A frequent finding associated with high mortalityPrado, F. A. / Delfino, V. D. / Grion, C. M. / de Oliveira, J. A. et al. | 2015
- 1219
-
Corrigendum to “Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites� [J Hepatol 2014;61:1004–1013]Yang, Y. Y. / Hsieh, S. L. / Lee, P. C. / Yeh, Y. C. / Lee, K. C. / Hsieh, Y. C. / Wang, Y. W. / Lee, T. Y. / Huang, Y. H. / Chan, C. C. et al. | 2015
- 1221
-
From the Editor’s desk...:June 2015Moreau, R. / Bataller, R. / Berg, T. / Zucman-Rossi, J. / Jalan, R. et al. | 2015
- 1225
-
Studies on the epidemiology of hepatitis B and C virus infections are still neededDeltenre, P. et al. | 2015
- 1228
-
Pharmacological chaperone therapies: Can aldehyde dehydrogenase activator make us healthier?Dollé, L. / Gao, B. et al. | 2015
- 1231
-
Intestinal failure to produce FGF19: A culprit in intestinal failure–associated liver disease?van Erpecum, K. J. / Schaap, F. G. et al. | 2015
- 1234
-
Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesityGonzalez, F. J. / Jiang, C. / Bisson, W. H. / Patterson, A. D. et al. | 2015
- 1237
-
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis BMenne, S. / Tumas, D. B. / Liu, K. H. / Thampi, L. / AlDeghaither, D. / Baldwin, B. H. / Bellezza, C. A. / Cote, P. J. / Zheng, J. / Halcomb, R. et al. | 2015
- 1246
-
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionFerenci, P. / Asselah, T. / Foster, G. R. / Zeuzem, S. / Sarrazin, C. / Moreno, C. / Ouzan, D. / Maevskaya, M. / Calinas, F. / Morano, L. E. et al. | 2015
- 1256
-
Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenariosWolffram, I. / Petroff, D. / Bätz, O. / Jedrysiak, K. / Kramer, J. / Tenckhoff, H. / Berg, T. / Wiegand, J. et al. | 2015
- 1265
-
Causes of death in people with chronic HBV infection: A population-based cohort studyMontuclard, C. / Hamza, S. / Rollot, F. / Evrard, P. / Faivre, J. / Hillon, P. / Di Martino, V. / Minello, A. et al. | 2015
- 1272
-
Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoidsGaskari, S. A. / Liu, H. / D’Mello, C. / Kunos, G. / Lee, S. S. et al. | 2015
- 1278
-
Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progressionHao, P. P. / Li, H. / Lee, M. J. / Wang, Y. P. / Kim, J. H. / Yu, G. R. / Lee, S. Y. / Leem, S. H. / Jang, K. Y. / Kim, D. G. et al. | 2015
- 1287
-
ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinomaChen, J. / Xia, H. / Zhang, X. / Karthik, S. / Pratap, S. V. / Ooi, L. L. / Hong, W. / Hui, K. M. et al. | 2015
- 1296
-
Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosisPiguet, A. C. / Saran, U. / Simillion, C. / Keller, I. / Terracciano, L. / Reeves, H. L. / Dufour, J. F. et al. | 2015
- 1304
-
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinomaKim, B. K. / Kim, S. U. / Kim, K. A. / Chung, Y. E. / Kim, M. J. / Park, M. S. / Park, J. Y. / Kim, D. Y. / Ahn, S. H. / Kim, M. D. et al. | 2015
- 1311
-
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in miceCui, K. / Yan, G. / Xu, C. / Chen, Y. / Wang, J. / Zhou, R. / Bai, L. / Lian, Z. / Wei, H. / Sun, R. et al. | 2015
- 1319
-
Hepatic p38α regulates gluconeogenesis by suppressing AMPKJing, Y. / Liu, W. / Cao, H. / Zhang, D. / Yao, X. / Zhang, S. / Xia, H. / Li, D. / Wang, Y. c. / Yan, J. et al. | 2015
- 1328
-
Repression of microRNA-130b by thyroid hormone enhances cell motilityLin, Y. H. / Wu, M. H. / Liao, C. J. / Huang, Y. H. / Chi, H. C. / Wu, S. M. / Chen, C. Y. / Tseng, Y. H. / Tsai, C. Y. / Chung, I. H. et al. | 2015
- 1341
-
Cell-autonomous decrease in proliferative competitiveness of the aged hepatocyteSerra, M. P. / Marongiu, F. / Marongiu, M. / Contini, A. / Laconi, E. et al. | 2015
- 1349
-
Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in miceCarambia, A. / Freund, B. / Schwinge, D. / Bruns, O. T. / Salmen, S. C. / Ittrich, H. / Reimer, R. / Heine, M. / Huber, S. / Waurisch, C. et al. | 2015
- 1357
-
Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganizationSzabo, S. / Wögenstein, K. L. / Österreicher, C. H. / Guldiken, N. / Chen, Y. / Doler, C. / Wiche, G. / Boor, P. / Haybaeck, J. / Strnad, P. et al. | 2015
- 1367
-
Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicityWin, S. / Than, T. A. / Le, B. H. / García-Ruiz, C. / Fernandez-Checa, J. C. / Kaplowitz, N. et al. | 2015
- 1375
-
Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in miceZhong, W. / Zhang, W. / Li, Q. / Xie, G. / Sun, Q. / Sun, X. / Tan, X. / Jia, W. / Zhou, Z. et al. | 2015
- 1382
-
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosisSilvestri, C. / Paris, D. / Martella, A. / Melck, D. / Guadagnino, I. / Cawthorne, M. / Motta, A. / Di Marzo, V. et al. | 2015
- 1391
-
Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failureMutanen, A. / Lohi, J. / Heikkilä, P. i. / Jalanko, H. / Pakarinen, M. P. et al. | 2015
- 1398
-
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesityMueller, M. / Thorell, A. / Claudel, T. / Jha, P. / Koefeler, H. / Lackner, C. / Hoesel, B. / Fauler, G. / Stojakovic, T. / Einarsson, C. et al. | 2015
- 1405
-
Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac diseaseReilly, N. R. / Lebwohl, B. / Hultcrantz, R. / Green, P. H. / Ludvigsson, J. F. et al. | 2015
- 1412
-
Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birdsXu, C. / Wan, X. / Xu, L. / Weng, H. / Yan, M. / Miao, M. / Sun, Y. / Xu, G. / Dooley, S. / Li, Y. et al. | 2015
- 1420
-
The yin and yang of evasion and immune activation in HCCMakarova-Rusher, O. V. / Medina-Echeverz, J. / Duffy, A. G. / Greten, T. F. et al. | 2015
- 1430
-
Biology of the immunomodulatory molecule HLA-G in human liver diseasesAmiot, L. / Vu, N. / Samson, M. et al. | 2015
- 1438
-
The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in ChineseWang, X. / Liu, Z. / Peng, Z. / Liu, W. et al. | 2015
- 1439
-
Is it worthy of switching to PegIFN alfa-2a in patients achieving virological suppression with entecavir?Wu, C. / Dunn, W. et al. | 2015
- 1440
-
Repeated transarterial chemoembolization: An overfitting effort?Facciorusso, A. / Bhoori, S. / Sposito, C. / Mazzaferro, V. et al. | 2015
- 1442
-
Reply to: ‘‘Repeated transarterial chemoembolization: An overfitting effort?’’Adhoute, X. / Penaranda, G. / Raoul, J. L. / Bourlière, M. et al. | 2015
- 1444
-
YAP in tumorigenesis: Friend or foe?Liu, S. / Pang, Q. / Zhang, J. / Liu, C. et al. | 2015
- 1445
-
Reply to: “YAP in tumorigenesis: Friend or foe?”Perra, A. / Kowalik, M. A. / Giordano, S. / Columbano, A. et al. | 2015
- 1446
-
Interferon regulatory factor 9 plays a dual function in health and diseaseYu, W. L. / Sun, Y. et al. | 2015
- 1447
-
Reply to: “Interferon regulatory factor 9 plays a dual function in health and disease”Zhang, X. J. / Wang, P. X. / Zhang, P. / Li, H. et al. | 2015
- 1449
-
To target or not to target viral antigens in HBV related HCC?Buschow, S. I. / Sprengers, D. / Woltman, A. M. et al. | 2015
- 1450
-
Reply to: “To target or not to target viral antigens in HBV related HCC?”Qasim, W. / Brunetto, M. / Gehring, A. J. / Maini, M. K. / Bonino, F. / Stauss, H. / Bertoletti, A. et al. | 2015
- 1452
-
Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!Giorgio, A. / Giorgio, V. / Matteucci, P. et al. | 2015
- 1453
-
Reply to: ‘‘Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!’’Forner, A. / Vilana, R. n. / Solé, M. / Bruix, J. et al. | 2015
- 1455
-
Erratum to “Inhibition of fibronectin deposition improves experimental liver fibrosis” [J Hepatol 2015;62:625–633]Altrock, E. / Sens, C. / Wuerfel, C. / Vasel, M. / Kawelke, N. / Dooley, S. / Sottile, J. / Nakchbandi, I. A. et al. | 2015
- 1457
-
First evidence-based guidelines for the diagnosis and management of hepatic encephalopathy: A welcome developmentDrenth, J. P. / Montagnese, S. et al. | 2015
- i
-
Editorial Board| 2015
- IBC
-
Join EASL. Take an active role in the most forward thinking and dynamic hepatology community worldwide| 2015
- IFC
-
The International Liver CongressTM 2016. Barcelona, Spain| 2015
- ix
-
Contents| 2015
- S1
-
Emerging trends in hepatology: 30years of the Journal of Hepatology and 50years of EASLJalan, R. et al. | 2015
- S4
-
30years of the Journal of Hepatology – The flagship journal and the crown-jewel of EASLPeck-Radosavljevic, M. et al. | 2015
- S6
-
Genetics of liver disease: From pathophysiology to clinical practiceKarlsen, T. H. / Lammert, F. / Thompson, R. J. et al. | 2015
- S15
-
Hepatic fibrosis: Concept to treatmentTrautwein, C. / Friedman, S. L. / Schuppan, D. / Pinzani, M. et al. | 2015
- S25
-
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyondBeuers, U. / Trauner, M. / Jansen, P. / Poupon, R. et al. | 2015
- S38
-
Trends in the management and burden of alcoholic liver diseaseMathurin, P. / Bataller, R. et al. | 2015
- S47
-
NAFLD: A multisystem diseaseByrne, C. D. / Targher, G. et al. | 2015
- S65
-
Current efforts and trends in the treatment of NASHRatziu, V. / Goodman, Z. / Sanyal, A. et al. | 2015
- S76
-
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugsLocarnini, S. / Hatzakis, A. / Chen, D. S. / Lok, A. et al. | 2015
- S87
-
From non-A, non-B hepatitis to hepatitis C virus curePawlotsky, J. M. / Feld, J. J. / Zeuzem, S. / Hoofnagle, J. H. et al. | 2015
- S100
-
Autoimmune hepatitis – Update 2015Manns, M. P. / Lohse, A. W. / Vergani, D. et al. | 2015
- S112
-
Acute liver failure: A curable disease by 2024?Bernal, W. / Lee, W. M. / Wendon, J. / Larsen, F. S. / Williams, R. et al. | 2015
- S121
-
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatmentsBosch, J. / Groszmann, R. J. / Shah, V. H. et al. | 2015
- S131
-
Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosisArroyo, V. / Moreau, R. / Jalan, R. / Ginès, P. et al. | 2015
- S144
-
Liver cancer: Approaching a personalized careBruix, J. / Han, K. H. / Gores, G. / Llovet, J. M. / Mazzaferro, V. et al. | 2015
- S157
-
Cell therapy for liver disease: From liver transplantation to cell factoryForbes, S. J. / Gupta, S. / Dhawan, A. et al. | 2015
- S170
-
From immunosuppression to toleranceAdams, D. H. / Sanchez-Fueyo, A. / Samuel, D. et al. | 2015
- S186
-
EASL Monothematic Conference, Liver Disease in Resource Limited Settings. Bucharest, Romania, 2015| 2015
- S187
-
G02 : Ledipasvir/sofosbuvir with ribavirin is safe and efficacious in decompensated and post liver transplantation patients with HCV infection: Preliminary results of the prospective solar 2 trialManns, M. / Forns, X. / Samuel, D. / Denning, J. / Arterburn, S. / Brandt-Sarif, T. / Dvory-Sobol, H. / Pang, P. S. / McHutchison, J. G. / Gane, E. et al. | 2015
- S189
-
G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinomaPark, J. W. / Cheng, A. L. / Kudo, M. / Park, J. H. / Liang, P. C. / Hidaka, H. / Izumi, N. / Heo, J. / Lee, Y. J. / Sheen, I. S. et al. | 2015
- S190
-
O002 : Treatment of decompensated HCV cirrhosis in patients with diverse genotypes: 12 weeks sofosbuvir and NS5A inhibitors with/without ribavirin is effective in HCV genotypes 1 and 3HCV, R. U. / Foster, G. R. / McLauchlan, J. / Irving, W. / Cheung, M. / Hudson, B. / Verma, S. / Agarwal, K. et al. | 2015
- S191
-
O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT): Interim data from the phase II saturn studyForns, X. / Berenguer, M. / Herzer, K. / Sterneck, M. / Donato, M. F. / Andreone, P. / Fagiuoli, S. / Cieciura, T. / Durlik, M. / Calleja, J. L. et al. | 2015
- S192
-
O006 : C-swift: grazoprevir/elbasvir + sofosbuvir in cirrhotic and noncirrhotic, treatment-naive patients with hepatitis C virus genotype 1 infection, for durations of 4, 6 or 8 weeks and genotype 3 infection for durations of 8 or 12 weeksPoordad, F. / Lawitz, E. / Gutierrez, J. A. / Evans, B. / Howe, A. / Feng, H. P. / Li, J. J. / Hwang, P. / Robertson, M. / Wahl, J. et al. | 2015
- S193
-
O008 : Efficacy and safety of grazoprevir and elbasvir in hepatitis C genotype 1-infected patients with child-pugh class B cirrhosis (C-salt part A)Jacobson, I. M. / Poordad, F. / Firpi-Morell, R. / Everson, G. T. / Verna, E. C. / Bhanja, S. / Zhang, B. / Caro, L. / Wahl, J. / Robertson, M. et al. | 2015
- S194
-
O010 : T and B cell responses and previous exposure to hepatitis B virus in ''anti-HBC alone'' patientsWang, Q. / Semmo, N. et al. | 2015
- S195
-
O012 : Hepatitis delta virus can survive liver regeneration and is amplified through human cell division both in vitro and in vivoGiersch, K. / Bhadra, O. D. / Volz, T. / Allweiss, L. / Lohse, A. W. / Petersen, J. / Sureau, C. / Urban, S. / Dandri, M. / Luetgehetmann, M. et al. | 2015
- S198
-
O017A : Non-invasive tools and risk of varices and clinically significant portal hypertension in compensated cirrhosis: the ''anticipate'' studyAbraldes, J. G. / Bureau, C. / Stefanescu, H. / Augustin, S. / Ney, M. / Procopet, B. / Bosch, J. / Genesca, J. / Berzigotti, A. et al. | 2015
- S199
-
O018 : 2D-shear wave elastography is equivalent or superior to transient elastography for liver fibrosis assessment: Results from an individual patient data based meta-analysisHerrmann, E. / de Ledinghen, V. / Cassinotto, C. / Chu, W. C. / Leung, V. Y. / Ferraioli, G. / Filice, C. / Castera, L. / Vilgrain, V. / Ronot, M. et al. | 2015
- S200
-
O020 : Magnetic resonance elastography is superior to clinical prediction models for determination of advanced fibrosis in patients with non-alcoholic fatty liver disease: A prospective studyCui, J. Y. / Wolfson, T. / Ang, B. / Haufe, W. / Hernandez, C. / Verna, E. C. / Sirlin, C. B. / Loomba, R. et al. | 2015
- S201
-
O022 : The UK-PBC risk score: Derivation and validation of a risk score to predict liver events in the UK-PBC research cohortCarbone, M. / Sharp, S. J. / Heneghan, M. A. / Neuberger, J. M. / Hirschfield, G. M. / Burroughs, A. K. / Thorburn, D. / Bathgate, A. / Aldersley, M. / Adgey, C. et al. | 2015
- S202
-
O025 : Role of CX3CL1-CX3CR1 axis for liver dendritic cell maturation in homeostasis and inflammationSutti, S. / Heymann, F. / Peusquens, J. / Trautwein, C. / Albano, E. / Tacke, F. et al. | 2015
- S203
-
O027 : The expression of tumor suppressor PTPRD is down-regulated in the liver of patients with HCV infection and in tumor lesions of patients with hepatocellular carcinomaVan Renne, N. / Duong, F. H. / Gondeau, C. / Calabrese, D. / Fontaine, N. / Ababsa, A. / Durand, S. C. / Pessaux, P. / Heim, M. H. / Baumert, T. F. et al. | 2015
- S204
-
O030 : Pro-apoptotic TNF receptor signaling is the result of a novel innate immune sensing pathway that determines cell death in virus-infected hepatocytesJanas, M. / Heikenwalder, M. / Knolle, P. / Wohlleber, D. et al. | 2015
- S206
-
O035 : CCR9 and CCL25 are early pro-inflammatory mediators in acute liver injuryParker, R. / Weston, C. / Possamai, L. A. / Petts, G. S. / Triantafyllou, E. / Bersmeier, C. / Khamri, W. / Wendon, J. / Antoniades, C. G. / Adams, D. H. et al. | 2015
- S209
-
O042 : Weight loss intensity is strongly associated to improvement of histological parameters in patients with nonalcoholic steatohepatitis after 52 weeks of lifestyle modificationVilar-Gomez, E. / Calzadilla, L. / Garcia, A. Y. / Perez, Y. M. / Romero-Gomez, M. / Diago, M. et al. | 2015
- S210
-
O044 : Distinct fecal and plasma bile acid metabolome of microbial origin characterizes human nonalcoholic fatty liver disease (NAFLD)Puri, P. / Siddiqui, S. M. / Boyette, S. / Sargeant, C. / White, L. D. / Walker, S. / Daita, K. / Ammons, C. / Cazanave, S. / Asgharpour, A. et al. | 2015
- S211
-
O047 : Remogliflozin etabonate reduces insulin resistance and liver function enzymes: Role for treatment of nashWilkison, W. / Cheatham, B. / Walker, S. et al. | 2015
- S213
-
G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)Ganne, N. / Bourcier, V. / Chaffaut, C. / Archambaud, I. / Oberti, F. / Perarnau, J. M. / Roulot, D. / Louvet, A. / Moreno, C. / Dao, T. et al. | 2015
- S215
-
O048 : First selective small molecule inhibitor of FGFR4 for the treatment of hepatocellular carcinomas with an activated FGFR4 signaling pathwayHoeflich, K. / Hagel, M. / Miduturu, C. / Sheets, M. / Rubin, N. / Weng, W. / Stransky, N. / Bifulco, N. / Kim, J. / Hodous, B. et al. | 2015
- S216
-
O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patientsBota, S. / Purevsambuu, T. / Hucke, F. / Reiberger, T. / Ferlitsch, A. / Hofer, H. / Sieghart, W. / Peck-Radosavljevic, M. et al. | 2015
- S217
-
O052 : Assessment of the hong kong liver cancer staging system in europeKolly, P. / Reeves, H. / Sangro, B. / Knopfli, M. / Candinas, D. / Dufour, J. F. et al. | 2015
- S218
-
O054 TM6SF2-T and PNPLA3-G genetic variants co-modulate the risk of hepatocellular carcinoma in caucasian patients with alcoholic cirrhosis. Inter-cohort validation in 1068 patientsNahon, P. / Cao, Q. / Guyot, E. / Rufat, P. / Sutton, A. / Ganne-Carrie, N. / Ziol, M. / Gustot, T. / Quertinmont, E. / Deviere, J. et al. | 2015
- S219
-
O056 : Ledipasvir/sofosbuvir treatment results in high SVR rates in patients with chronic genotype 4 and 5 HCV infectionAbergel, A. / Loustaud-Ratti, V. / Metivier, S. / Jiang, D. / Kersey, K. / Knox, S. J. / Pang, P. S. / Samuel, D. / Asselah, T. et al. | 2015
- S221
-
061 : Incidence of hepatitis C reinfection following sustained virological response - A seven year follow-up of scandinavian patients infected through injecting drug useMidgard, H. / Bjoro, B. / Dalgard, O. et al. | 2015
- S222
-
O063 : HCV reinfection cases in phase 3 studies of sofosbuvirSvarovskaia, E. / Martin, R. / Chodavarapu Chodavarapu, K. / Hedskog Hedskog, C. / Brainard, D. / Miller, M. D. / Mo, H. et al. | 2015
- S224
-
O068 : Lysosomal cholesterol in kupffer cells, particularly when oxidized, contributes to murine steatohepatitisWalenbergh, S. / Houben, T. / Hendrikx, T. / van Gorp, P. / Jeurissen, M. / Bieghs, V. / Lenders, M. H. / Gijbels, M. / Plat, J. / Hofker, M. et al. | 2015
- S226
-
O072 : Statin use significantly decreases decompensation and death in veterans with hepatitis C-related compensated cirrhosisMohanty, A. / Tate, J. P. / Garcia-Tsao, G. et al. | 2015
- S227
-
O074 : A metabolomic study of serum from patients with cirrhosis identifies 2 metabolites that accurately predict the acute HVPG response to b-blocker therapyReverter, E. / Lozano, J. J. / Alonso, C. / Berzigotti, A. / Seijo, S. / Turon, F. / Martinez-Chantar, M. L. / Maria Mato, J. / Hernandez-Gea, V. / Bosch, J. et al. | 2015
- S230
-
O080 : Early clinical features associated with long-term risk of transplantation in primary sclerosing cholangitis: Results from the UK-PSC consortiumUK-PSC, C. / Goode, E. C. / Srivastava, B. / Clark, A. B. / Spiess, K. / Hirschfield, G. M. / Gelson, W. T. / Trivedi, P. J. / Mells, G. F. / Sandford, R. N. et al. | 2015
- S231
-
O082 : The gut microbiota in primary sclerosing cholangitis differs from that of healthy controls and ulcerative colitis patients without biliary diseaseKummen, M. / Holm, K. / Anmarkrud, J. A. / Vesterhus, M. / Hoivik, M. L. / Troseid, M. / Marschall, H. U. / Schrumpf, E. / Moum, B. / Aukrust, P. et al. | 2015
- S232
-
O085 : Lanreotide reduces liver volume yet accelerates muscle wasting and weight loss in symptomatic polycystic liver diseaseTemmerman, F. / Ho, T. A. / Vanslembrouck, R. / Coudyzer, W. / Billen, J. / Dobbels, F. / van Pelt, J. / Bammens, B. / Pirson, Y. / Nevens, F. et al. | 2015
- S233
-
O087 : IgG4+ B-cell receptor clones in peripheral blood distinguish IgG4-associated cholangitis/autoimmune pancreatitis from primary sclerosing cholangitisHubers, L. M. / Doorenspleet, M. E. / Culver, E. L. / Maillette de Buy Wenniger, L. J. / Klarenbeek, P. L. / Van de Graaf, S. F. / Verheij, J. / Van Gulik, T. M. / Baas, F. / Barnes, E. et al. | 2015
- S235
-
G14 : Systemic inflammatory response syndrome (SIRS) is a major determinant of treatment response to terlipressin for hepatorenal syndrome type 1 (HRS-1)on behalf, o. T. / Wong, F. / Pappas, S. C. / Boyer, T. D. / Sanyal, A. J. / Jamil, K. et al. | 2015
- S236
-
G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohortCoilly, A. / Fougerou, C. / De Ledinghen, V. / Houssel-Debry, P. / Duvoux, C. / Di Martino, V. / Radenne, S. / Kamar, N. / D'Alteroche, L. / Leroy, V. et al. | 2015
- S239
-
O090 : Humanization of germ-free mice with alcoholic cirrhotic microbiota, but not healthy microbiota, induces bacterial translocation and a pro-inflammatory milieu, which is ameliorated with lactobacillus GGKang, D. J. / Hylemon, P. B. / Sartor, R. B. / Kakiyama, G. / Gillevet, P. / Heuman, D. M. / Pandak, W. M. / Ridlon, J. M. / Fiehn, O. / Grapov, D. et al. | 2015
- S240
-
O092 : Microbiological assessment of ascitic fluid in liver disease: Culture techniques, sensitivities and interpretationSutherland, D. / Buckle, F. / Altmeyer, U. / Priest, M. / Barclay, S. / Stanley, A. / Forrest, E. et al. | 2015
- S241
-
O094 : The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitison behalf, o. V. / Mandorfer, M. / Bota, S. / Schwabl, P. / Pfisterer, N. / Goliasch, G. / Fuhrmann, V. / Horvatits, T. / Ferlitsch, A. / Sieghart, W. et al. | 2015
- S243
-
O099 : Cysteine cathepsins control liver inflammation through regulation of sirtuin-1 action on p65-NFkB subunitde Mingo, A. / Morales, A. / Fernandez-Checa, J. / Mari, M. et al. | 2015
- S245
-
O104 : Predictive model for the need for liver transplantation in symptomatic polycystic liver diseaseon behalf, o. t. / Temmerman, F. / Oliverius, M. / Lerut, J. / Drenth, J. P. / Metselaar, H. / Coudyzer, W. / Vanslembrouck, R. / van Pelt, J. / Bammens, B. et al. | 2015
- S246
-
O106 : Therapeutic plasma exchange modulates innate immune activation and improves outcome in patients with acute liver failureBernsmeier, C. / Patel, V. C. / Singanayagam, A. / Yuksel, M. / Huang, X. / Willars, C. / Bernal, W. / Auzinger, G. / Ma, Y. / Larsen, F. S. et al. | 2015
- S247
-
O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT studythe, A. C. / Dumortier, J. / Botta-Fridlund, D. / Coilly, A. / Leroy, V. / Fougerou-Leurent, C. / Danjou, H. / Radenne, S. / Durand, F. / Kamar, N. et al. | 2015
- S248
-
O111 : Operational tolerance causes a long lasting active immunoregulation within the graftTaubert, R. / Danger, R. / Londono, M. C. / Martinez, M. / Rimola, A. / Manns, M. P. / Sanchez-Fueyo, A. / Jaeckel, E. et al. | 2015
- S249
-
O113 : HLA DPB1 rs9277535 polymorphism strongly predicts HBsAg clearance in IFN treated genotype D HBeAg-negative patients with chronic hepatitis BLampertico, P. / Galmozzi, E. / Facchetti, F. / Cheroni, C. / Invernizzi, F. / Valveri, V. / Soffredini, R. / Vigano, M. / Abrignani, S. / De Francesco, R. et al. | 2015
- S251
-
O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)Chan, H. L. / Ahn, S. H. / Chuang, W. L. / Hui, A. J. / Tabak, F. / Mehta, R. / Petersen, J. / Lee, C. M. / Ma, X. / Caruntu, F. A. et al. | 2015
- S253
-
O120 : Advanced fibrosis is common in individuals whose hepatitis C has not been diagnosed: Results from the national health and nutrition examination survey 2001-2012Udompap, P. / Mannalithara, A. / Heo, N. Y. / Kim, W. R. et al. | 2015
- S254
-
O122 : Clinical impact of five large-scale screening projects for chronic hepatitis B and C in Chinese migrants in The NetherlandsCoenen, S. / van Meer, S. / Vrolijk, J. M. / Richter, C. / Drenth, J. P. / Koopmans, P. P. / van Soest, H. / van Erpecum, K. J. / Arends, J. E. / Verhagen, M. A. et al. | 2015
- S255
-
O124 : Is increased HCV case-finding combined with 8 or 12 week interferon-free direct-acting antiviral treatment cost-effective in UK prisons? a cost utility analysis including treatment as prevention benefitsMartin, N. K. / Vickerman, P. / Brew, I. F. / Williamson, J. / Irving, W. J. / Sakshena, S. / Hutchinson, S. J. / Hickman, M. et al. | 2015
- S256
-
O127 : A worldwide study reveals that the amount of daily alcohol intake is a better predictor of the weight of alcohol in the cirrhosis burden than the total per capita comsumptionBataller, R. / Stein, E. / Altamirano, J. T. / Cruz-Lemini, M. / Cheong, J. et al. | 2015
- S257
-
LO2 : Significant reduction of HBsAg and HDV RNA by the nucleic acid polymer REP 2139 in caucasian patients with chronic HBV/HDV co-infectionBazinet, M. / Pantea, V. / Cebotarescu, V. / Cojuhari, L. / Jimbei, P. / Vaillant, A. et al. | 2015
- S258
-
LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather*on behalf, o. H. / Pol, S. / Bourliere, M. / Lucier, S. / De Ledinghen, V. / Zoulim, F. / Dorival-Mouly, C. / Metivier, S. / Larrey, D. / Tran, A. et al. | 2015
- S259
-
LO5 : Sofosbuvir + peginterferon/ribavirin for 12 weeks vs sofosbuvir + ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experienced cirrhotic patients with genotype 2 HCV: The boson studyFoster, G. R. / Pianko, S. / Cooper, C. / Brown, A. / Forton, D. / Nahass, R. G. / George, J. / Barnes, E. / Brainard, D. M. / Massetto, B. et al. | 2015
- S260
-
LO6 : A two-stage genome-wide association study identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosisBuch, S. / Stickel, F. / Trepo, E. / Way, M. / Herrmann, A. / Nischalke, H. D. / Brosch, M. / Rosendahl, J. / Berg, T. / Fischer, J. et al. | 2015
- S261
-
LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 studyPoordad, F. / Schiff, E. R. / Vierling, J. M. / Landis, C. / Fontana, R. J. / Yang, R. / McPhee, F. / Hughes, E. / Noviello, S. / Swenson, E. S. et al. | 2015
- S263
-
LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney diseaseRoth, D. / Nelson, D. / Bruchfeld, A. / Liapakis, A. / Silva, M. / Monsour, H. / Martin, P. / Pol, S. / Londono, M. C. / Hassanein, T. et al. | 2015
- S264
-
LP04 : A phase 3, open-label, single-arm study to evaluate the efficacy and safety of 12 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-naive or -experienced patients with chronic HCV genotype 1 infection and cirrhosis: Optimist-2Lawitz, E. / Matusow, G. / DeJesus, E. / Yoshida, E. / Felizarta, F. / Ghalib, R. / Godofsky, E. / Herring, R. / Poleynard, G. / Sheikh, A. et al. | 2015
- S265
-
LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use programon behalf, o. B. / Hezode, C. / De Ledinghen, V. / Fontaine, H. / Zoulim, F. / Lebray, P. / Boyer, N. / Larrey, D. / Silvain, C. / Botta-Fridlund, D. et al. | 2015
- S266
-
LP07 : Simeprevir (SMV) plus daclatasvir (DCV) and sofosbuvir (SOF) in treatment-naive and -experienced patients with chronic hepatitis C virus genotype 1 or 4 infection and decompensated liver disease: Interim results from the phase II impact studyLawitz, E. / Poordad, F. / Gutierrez, J. / Kakuda, T. / Picchio, G. / Rosa, G. D. / Beets, G. / Vandevoorde, A. / Van Remoortere, P. / Jacquemyn, B. et al. | 2015
- S267
-
LP09 : High efficacy of retreatment with ledipasvir and sofosbuvir in HCV patients who failed initial short course therapy with combination DAA regimens (nih synergy trial)Wilson, E. M. / Kattakuzhy, S. / Sims, Z. / Tang, L. / McLaughlin, M. / Price, A. / Silk, R. / Gross, C. / Akoth, E. / Osinusi, A. et al. | 2015
- S268
-
LP11 : Warfarin anticoagulation for liver fibrosis in patients transplanted for hepatitis C (WAFT-C): results at one yearDhar, A. / Tschotazis, E. / Brown, R. / Manousou, P. / Millson, C. / Aldersley, M. / Forbes, S. / Aggarwal, K. / Gera, A. / Cramp, M. et al. | 2015
- S269
-
LP13 : Effect of long term viral suppression with sofosbuvir + ribavirin on hepatic venous pressure gradient in HCV-infected patients with cirrhosis and portal hypertensionAfdhal, N. / Everson, G. T. / Calleja, J. / McCaughan, G. / Bosch, J. / Denning, J. / Brainard, D. M. / McHutchison, J. G. / Brandt-Sarif, T. / An, D. et al. | 2015
- S271
-
LP17 : Novel approach for the prevention of recurrent hepatitis C in liver transplant recipients: Preliminary results from ongoing phase III trial with civacirTerrault, N. / Shrestha, R. / Satapathy, S. K. / O'Leary, J. G. / Campsen, J. / Rosenau, J. / Spivey, J. / Teperman, L. W. / Therapondos, G. / Verna, E. C. et al. | 2015
- S273
-
LP20 : Safety and efficacy of all-oral daa regimens in HIV-HCV coinfected cirrhotic patients from the prospective ANRS CO13 - HEPAVIH cohorton behalf, o. A. / Sogni, P. / Gilbert, C. / Lacombe, K. / Piroth, L. / Rosenthal, E. / Dominguez, S. / Chas, J. / Neau, D. / Poizot-Martin, I. et al. | 2015
- S274
-
LP22 : Phase 1 results from PXS-4728A, a selective SSAO/VAP-1 inhibitor, for the treatment of non-alcoholic steatohepatitisJarolimek, W. / Charlton, B. et al. | 2015
- S278
-
LP29 : A randomised prospective open-label trial comparing peginterferon + adefovir and peginterferon + tenofovir versus no treatment in hbeag negative chronic hepatitis b patients with low viral load: analysis of week 48 resultsde Niet, A. / Jansen, L. / Stelma, F. / Willemse, S. B. / Kuiken, S. D. / Weijer, S. / van Nieuwkerk, K. M. / Zaaijer, H. L. / Molenkamp, R. / Takkenberg, R. B. et al. | 2015
- S279
-
LP31 : Strengthening viral hepatitis surveillance in europe: Recommendations from two global hepatitis policy surveys (2013 and 2014)Mozalevskis, A. / Sperle, I. / Safreed-Harmon, K. / Eramova, I. / Donoghoe, M. C. / Lazarus, J. V. et al. | 2015
- S280
-
LP34 : Ex vivo liver resection and autotransplantation: A feasible and highly effective procedure for patients with end-stage alveolar echinococcosis - 15 cases experienceWen, H. / Dong, J. H. / Zhang, J. H. / Duan, W. D. / Zhao, J. M. / Liang, Y. R. / Shao, Y. M. / Ji, X. W. / Tai, Q. W. / Li, T. et al. | 2015
- S281
-
LP36 : Understanding hepatitis delta virus and HBsAG kinetics during treatment with prenylation inhibitor lonafarnib via mathematical modelingCanini, L. / Koh, C. / Cotler, S. J. / Zhao, X. / Uprichard, S. L. / Haynes-Williams, V. / Winters, M. A. / Subramanya, G. / Cooper, S. L. / Pinto, P. et al. | 2015
- S282
-
LP38 : Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from austriaBeinhardt, S. / Freissmuth, C. / Al-Zoairy, R. / Kozbial, K. / Hametner, S. / Stern, R. / Stauber, R. / Maieron, A. / Staufer, K. / Strasser, M. et al. | 2015
- S283
-
LP40 : SB 9200, A novel immunomodulator for patients with viral hepatitis: Phase 1 mad study in patients with hepatitis c virus (HCV) infectionThompson, A. / Roberts, S. / Cheng, W. / Angus, P. / Visvanathan, K. / Iyer, R. / Barclay, M. et al. | 2015
- S284
-
LP42 : Safety and efficacy of novel antivirals in kidney transplant recipients with chronic hepatitis c virus (HCV) infectionLin, M. V. / Sise, M. E. / Pavlakis, M. / Hanifi, J. M. / Rutherford, A. E. / Elias, N. / Heher, E. C. / Curry, M. P. / Riella, L. V. et al. | 2015
- S285
-
LP44 : Phagocytosis: How the beginning programs the end in the damaged liverCampana, L. / Pellicoro, A. / Aucott, R. / Greenalgh, S. / Anderton, S. / Iredale, J. P. et al. | 2015
- S286
-
LP46 : Occult HBV is highly prevalent in patients with intrahepatic cholangiocarcinoma and it is detected as both free episomal and integrated DNAPollicino, T. / Musolino, C. / Tripodi, G. / Lanza, M. / Raffa, G. / Saitta, C. / Benfatto, S. / Beninati, C. / Navarra, G. / Invernizzi, P. et al. | 2015
- S287
-
LP49 : Sofosbuvir containing regimes to patients with HCV genotype 3 infection. A scandinavian real-life experienceThe Danish, S. a. / Dalgard, O. / Weis, N. / Noraberg, G. / Isaksen, K. / Oevrehus, A. / Skalshoj Skjaer, M. / Weiland, O. et al. | 2015
- S288
-
LP52 : Nonalcoholic fatty liver disease (NAFLD) as potential risk factor of cardiovascular disease and oncological disease in diabetic type 2 patientsCaroli, D. / Nogara, A. / Rosa-Rizzotto, E. / Bariga, A. B. / Zanoni, S. / De Boni, S. / Cavallarin, G. / Marafin, C. / Inglese, M. / Loggia, M. D. et al. | 2015
- S289
-
LP54 : Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirinDao Thi, V. L. / Debing, Y. / Neyts, J. / Moradpour, D. / Gouttenoire, J. et al. | 2015
- S290
-
P0001 : Early monocyte dysfunction in patients who develop Systemic Inflammatory Response Syndrome (SIRS) and sepsis after hepatopancreaticobiliary surgeryLahiri, R. / Derwa, Y. / Bashir, Z. / Giles, E. / Torrance, H. / O'Dwyer, M. / Owen, H. / O'Brien, A. / Stagg, A. / Bhattacharya, S. et al. | 2015
- S291
-
P0003 : Sequential expression profiles of cannabinoid receptors on immune cells and release of cytokines during liver regenerationGupta, A. C. / Sharma, S. / Sehgal, R. / David, P. / Sasturkar, S. / Pamecha, V. / Trehanpati, N. / Sarin, S. K. et al. | 2015
- S293
-
P0008 : A multidrug strategy to attenuate ischemia reperfusion injury in experimental liver transplantationYamanaka, K. / Houben, P. / Bruns, H. / Schultze, D. / Hatano, E. / Schemmer, P. et al. | 2015
- S295
-
P0013 : Resolvin D1 protects livers from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosisKang, J. W. / Shin, J. K. / Choi, J. W. / Cho, H. I. / Lee, S. M. et al. | 2015
- S296
-
P0016 : Visualization of liver regeneration after 70% partial hepatectomy in miceXie, C. / Wei, W. / Dahmen, U. et al. | 2015
- S297
-
P0018 : Adenosine protects liver against oxidative stress damage in liver Ischemia/Reperfusion (I/R) injuryVeljkovic, A. / Kocic, G. / Cvetkovic, T. / Sokolovic, D. / Radojkovic, M. / Jevtovic, T. / Djordjevic, B. / Despotovic, M. et al. | 2015
- S299
-
P0023 : Comparison of the C3A and HepaRG liver cell lines in monolayer and 3D for bioartificial liver applicationVan Wenum, M. / Chamuleau, R. A. / Hendriks, E. J. / van Gulik, T. M. / Adam, A. A. / Hoekstra, R. et al. | 2015
- S300
-
P0025 : The public health value of sparing livers for transplantation through systematic treatment of hepatitis CStevens, W. / Sanchez, Y. / Brookmeyer, R. / Lakdawalla, D. / Marx, S. / Juday, T. et al. | 2015
- S301
-
P0027 : Cost-effectiveness of pre-transplant sofosbuvir to prevent recurrence of HCV infection after liver transplantationLiver, T. N. / Vitale, A. / Spolverato, G. / Burra, P. / Cillo, U. / Fagiuoli, S. et al. | 2015
- S302
-
P0030 : Utility based criteria to select patients with hepatocellular carcinoma for liver transplantation: A multicentre cohort studyITA.LI.CA., s. g. / Vitale, A. / Farinati, F. / Trevisani, F. / Burra, P. / Giannini, E. G. / Spolverato, G. / Cillo, U. et al. | 2015
- S303
-
P0032 : The impact of Ischemia/Reperfusion injury on liver allografts from deceased after cardiac death versus deceased after brain death donorsAmir Sayed, B. / Xu, J. / Casas-Ferreira, A. M. / Srinivasan, P. / Heaton, N. / Ma, Y. / Legido-Quigley, C. / Fuggle, S. / Jassem, W. et al. | 2015
- S304
-
P0035 : Are there demographic, behavioural and psychosocial factors that predict alcohol consumption before or after liver transplantation?Aldersley, H. C. / Rinomhota, A. S. / Farid, S. / Rothwell, K. L. / Shepherd, E. A. / Aldersley, M. A. et al. | 2015
- S306
-
P0040 : Long-term cardiovascular mortality after liver transplantation: Analysis of risk factorsD'Avola, D. / Cuervas-Mons, V. / Marti, J. / Ortiz de Urbina, J. / Llado, L. / Jimenez, C. / Otero, E. / Suarez, F. / Rodrigo, J. M. / Gomez, M. A. et al. | 2015
- S307
-
P0043 : Rate of employment after liver transplantation in france: A single centre studyRudler, M. / Rousseau, G. / Lebray, P. / Vaillant, J. C. / Savier, E. / Eyraud, D. / Poynard, T. / Thabut, D. et al. | 2015
- S308
-
P0045 : Long term low dose steroid triple immunosuppressive regimens in post transplant autoimmune hepatitis (AIH) patients reduces the incidence of recurrent disease and is not associated with increased mortalityKrishnamoorthy, T. L. / Miezynska-Kurtycz, J. / Hodson, J. / Gunson, B. K. / Neuberger, J. / Milkiewicz, P. / Oo, Y. H. et al. | 2015
- S309
-
P0047 : Recipient (but not donor) adiponectin polymorphisms are associated with post transplant hepatic steatosisJohn, B. / Garber, A. / Aiken, T. / Thomas, D. / Konjeti, R. / Chen, D. / Lopez, R. / Fung, J. J. / Askar, M. et al. | 2015
- S310
-
P0050 : Neurological syndrome 'de novo' in familial amyloidotic polyneuropathy after liver transplantCentro, H. B. / Mateus, E. M. / Mega, I. / Morbey, A. / Veloso, J. / Perdigoto, R. / Gloria, H. / Machado, J. / Martins, A. / Barroso, E. et al. | 2015
- S311
-
P0053 : Dinstict intrahepatic cytokine profiles for the differentiaton of acute cellular rejection vs recurrent hepatitis C in liver transplanted patientsFytili, P. / Krech, T. / Gonnermann, A. / Groszhennig, A. / Jonigk, D. / Lehner, F. / Manns, M. P. / Koch, A. / Becker, J. U. / Wedemeyer, H. et al. | 2015
- S313
-
P0058 : Sofosbuvir-based antiviral therapy is highly effective in recurrent hepatitis c in liver transplant recipients: A ''real-life'' canadian multicenter experienceFaisal, N. / Bilodeau, M. / Aljudaibi, B. / Peltekian, K. / Yoshida, E. M. / Hussaini, T. / Ghali, P. / Congly, S. E. / Ma, M. / Cooper, C. et al. | 2015
- S314
-
P0060 : Antiviral therapy with sofosbuvir plus ribavirin in HCV-infected cirrhotic patients awaiting liver transplantation: Preliminary data from a single-centre experienceStrona, S. / Martini, S. / Arese, D. / Sacco, M. / Romagnoli, R. / Tandoi, F. / Ottobrelli, A. / Cerenzia, M. R. / Balzola, F. / Salizzoni, M. et al. | 2015
- S315
-
P0062 : Changes in cerebral hemodynamics in cirrhotic patients after liver transplantationMacias-Rodriguez, R. U. / Garcia Flores, O. / Ruiz-Margain, A. / Cantu-Brito, C. / Torre, A. et al. | 2015
- S316
-
P0065 : Effect of portal vein thrombosis (PVT) on survival after liver transplantation (LT): A metanalysisZanetto, A. / Rodriguez-Castro, K. I. / Nadal, E. / Ferrarese, A. / Germani, G. / Russo, F. P. / Burra, P. / Senzolo, M. et al. | 2015
- S318
-
P0069 : Risk factors for metabolic syndrome after liver transplantation: What has changed over timeVanni, E. / Ibrahim Kamal Jouness, R. / Mirabella, S. / Marengo, A. / Milan, A. / Rosso, C. / Boano, V. / Mosso, E. / Di Stefano, C. / Nada, E. et al. | 2015
- S319
-
P0072 : Microinvasive intraoperative ultrasound pattern in predicting outcomes for single small (<3cm) hepatocellular carcinomaCosta, M. / Santambrogio, R. / Barabino, M. / Zuin, M. / Bertolini, E. / Opocher, E. et al. | 2015
- S321
-
P0077 : Improvement of liver elasticity in HCV-patients under sofosbuvir-based therapy after liver transplantationSeifert, L. L. / Vorona, E. / Bester, C. / Beckebaum, S. / Kabar, I. / Baier, P. / Husing, A. / Stahl, M. / Cicinnati, V. / Schmidt, H. H. et al. | 2015
- S322
-
P0079 : Nucleos(t)ide analogue prophylaxis after hepatitis B immunoglobulin withdrawal is safe and effective against hepatitis B and D recurrence after liver transplantationCholongitas, E. / Vasiliadis, T. / Goulis, I. / Antoniadis, N. / Chalevas, P. / Fouzas, I. / Giakoustidis, D. / Imvrios, G. / Giouleme, O. / Papanikolaou, V. et al. | 2015
- S323
-
P0081 : Reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapyOnali, S. / Mansell, A. / Aspite, S. / De Luca, L. / Tsochatzis, E. / O'Beirne, J. / Patch, D. / Thorburn, D. / Pinzani, M. / Manousou, P. et al. | 2015
- S324
-
P1295 : Role of CK 18 (M30) in predicting mortality in patients with acute liver failureKar, P. / Malik, C. / Hazam, R. K. / Bagchi, A. / Chakravarti, A. et al. | 2015
- S326
-
P1300 : Spheroid reservoir bioartificial liver treatment inhibits alpha-amanitin induced fulminant hepatic failure in rhesus monkey modelBao, J. / Bu, H. / Nyberg, S. et al. | 2015
- S327
-
P1302 : Evidence for the ICG-clearance-test as a relevant predictor of post hepatectomy liver failureHaegele, S. / Offensperger, F. / Lahner, E. / Assinger, A. / Fleischmann, E. / Gruenberger, B. / Gruenberger, T. / Brostjan, C. / Starlinger, P. et al. | 2015
- S328
-
P1305 : Mitochondrial function is preserved in cerebral cortex in a rat model of acute hyperammonaemia and systemic inflammationNissen Bjerring, P. / Witt, A. M. / Larsen, F. S. et al. | 2015
- S333
-
P0089 : Plasma betatrophin levels in patients with liver cirrhosisArias, M. T. / Garcia-Unzueta, M. / Llerena, S. / Iruzubieta, P. / Puente, A. / Cabezas, J. / Alonso, C. / Cuadrado, A. / Amado, J. A. / Crespo, J. et al. | 2015
- S335
-
P0094 : Impaired 11b-hydroxysteroid dehydrogenase type 2 activity contributes to renal sodium avidity in human cirrhosisDam Fialla, A. / Thiesson, H. C. / Bie, P. / Hovind, P. H. / Schaffalitzky de Muckadell, O. B. / Krag, A. et al. | 2015
- S336
-
P0097 : Precisely quantitating the dynamics of liver cirrhosis in a rat modelWang, Y. / Liu, H. / Huang, X. / Lin, C. et al. | 2015
- S338
-
P0102 : Degeneration signs of Purkinje neurons in a new animal model of episodic hepatic encephalopathyGarcia-Lezana, T. / Romero-Gimenez, J. / Oria, M. / Genesca, J. / Chavarria, L. / Cordoba, J. et al. | 2015
- S339
-
P0104 : The liver sinusoid within a microfluidic chamber: A new tool for vascular biology researchMaeso-Diaz, R. / Illa, X. / Vila, S. / Yeste, J. / Marrone, G. / Navarro-Zornoza, M. / Peralta, C. / Villa, R. / Gracia-Sancho, J. et al. | 2015
- S340
-
P0106 : Reduced expression of Glyoxalase-I in cirrhotic livers: A mechanism that could explain higher concentration of Reactive Oxygen Species (ROS) in the development of cirrhosisHollenbach, M. / Thonig, A. / Pohl, S. / Ripoll, C. / Zipprich, A. et al. | 2015
- S341
-
P0109 : Elevation of cathepsin L and B expression in liver fibrosis: A study in mice models and patientsManchanda, M. / Roeb, E. / Roderfield, M. / Gupta, S. D. / Das, P. / Singh, R. / Chauhan, S. S. et al. | 2015
- S344
-
P0118 : Phase 1-2 clinical trial in patients with decompensated liver cirrhosis treated with bone-marrow derived endothelial progenitor cellsD'Avola, D. / Fernandez-Ruiz, V. / Carmona de la Torre, F. / Mendez, M. / Prosper, F. / Andreu, E. / Herrero, J. I. / Inarrairaegui, M. / Fuertes, C. / Sangro, B. et al. | 2015
- S345
-
P0120 : The 3-month readmission rate remains unacceptably high in a large multi-center cohort of cirrhotic patientson behalf, o. N. / Bajaj, J. S. / Reddy, K. R. / Garcia-Tsao, G. / Wong, F. / Fallon, M. B. / Subramanian, R. / Biggins, S. W. / Maliakkal, B. / Kamath, P. S. et al. | 2015
- S347
-
P0125 : Hepatopulmonary syndrome (HPS) screening in patients with child A/B liver cirrhosisNavascues, C. A. / Angel de Jorge, M. / Gonzalez-Dieguez, L. / Cadahia, V. / Varela, M. / Hevia, S. / Fernandez, R. / Rodriguez, M. et al. | 2015
- S348
-
P0127 : Patient-reported health-related quality of life outcomes independently predict death, transplant, hospitalization and hepatic encephalopathy in cirrhosisPatidar, K. / Thacker, L. / Wade, J. / White, M. / Unser, A. / Gavis, E. / Hovermale, J. / Sterling, R. K. / Fuchs, M. / Siddiqui, M. S. et al. | 2015
- S349
-
P0130 : VITRO-Score (vWF-Ag/thrombocytes) predicts mortality in patients with liver cirrhosis independent of child-pugh stage and meld scoreMaieron, A. / Hametner, S. / Etschmaier, A. / Schofl, R. / Ziachehabi, A. / Ferlitsch, A. et al. | 2015
- S350
-
P0132 : External validation of the CLIF-SOFA in cirrhotic patients admitted to intensive care units (ICUS): A meta-analysisMETAREACIR, G. / Weil, D. / Di Martino, V. / Levesque, E. / McPhail, M. / Cavallazzi, R. / Theocharidou, E. / Cholongitas, E. / Galbois, A. / Pan, H. C. et al. | 2015
- S351
-
P0135 : Impact of vasopressin AVP1A receptor gene polymorphisms on mortality and renal failure in patients with acute decompensation of chronic liver diseaseSchaapman, J. J. / Kerbert, A. C. / van der Reijden, J. J. / Amoros Navarro, A. / Pavesi, M. / van Hoek, B. / Arroyo, V. / Bernardi, M. / Soriano, G. / Catalina, M. V. et al. | 2015
- S352
-
P0137 : Safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation. Analysis from a French multicenter, open-label study (ANRS HC29 bocepretransplant)Fontaine, H. / Maynard-Muet, M. / Bouix, C. / Botta-Fridlund, D. / D'Alteroche, L. / Conti, F. / Pageaux, G. P. / Leroy, V. / Metivier, S. / Anty, R. et al. | 2015
- S353
-
P0139 : Patients experiencing repeated episodes of hepatic encephalopathy have increasing risk of death. A post HOC analysis of rifaximin-a open label study dataBannister, C. A. / Conway, P. / Radwan, A. / Morgan, C. L. / Berni, E. / Currie, C. J. et al. | 2015
- S354
-
P0142 : Mortality risk factors in cirrhotic patients in Intensive Care Unit: A monocentric retrospective study at Besancon's University Hospital from 2002 to 2014Chaignat, C. / Piton, G. / Capellier, G. / Patry, C. / Cervoni, J. P. / Di Martino, V. et al. | 2015
- S355
-
P0144 : Two testing strategies for covert hepatic encephalopathy diagnosis stabilizes agreement between sites in a multi-center analysis: validation of the EASL/AASLD he guidelinesAllampati, S. / Duarte-Rojo, A. / Thacker, L. / White, M. / Unser, A. / Gavis, E. / Hovermale, J. / Heuman, D. M. / John, B. / Klair, J. S. et al. | 2015
- S356
-
P0146 : Oral, once-daily, cenicriviroc leads to rapid and potent CCR2 and CCR5 blockade in subjects with advanced liver disease, similar to effects seen in healthy volunteers and HIV-1 infected subjectsUtay, N. S. / Gottwald, M. / Chang, W. / Willett, M. S. / Lefebvre, E. et al. | 2015
- S359
-
P0153 : Insulin-like growth factor-binding protein 3 (IGFBP3) serum levels are associated with prognosis in patients admitted for acute decompensation of cirrhosisCorrea, C. G. / Colombo, B. S. / Ronsoni, M. F. / Soares e Silva, P. E. / Fayad, L. / Wildner, L. M. / Bazzo, M. L. / Dantas-Correa, E. / Narciso-Schiavon, J. L. / Schiavon, L. L. et al. | 2015
- S360
-
P0155 : Validity and reliability of splenic volume measurement by ultrasound and its clinical implications to define splenomegaly in liver cirrhosisKim, S. G. / Jung, H. J. / Kim, Y. S. / Lee, S. H. / Jeong, S. W. / Jang, J. Y. / Kim, Y. D. / Cheon, G. J. / Kim, H. S. / Kim, B. S. et al. | 2015
- S361
-
P0158 : Influence of sustained viral response in the regression of fibrosis and portal hypertension in cirrhotic HCV genotype 1 patients treated with triple therapyPuente, A. / Cabezas, J. / Arias Loste, M. T. / Estebanez, A. / Fortea, J. I. / Cuadrado, A. / Fabrega, E. / Casafont, F. / Crespo, J. et al. | 2015
- S362
-
P0160 : Liver cirrhosis in Southern Sweden 2001-2011: A population-based studyNilsson, E. / Sargenti, K. / Anderson, H. / Prytz, H. et al. | 2015
- S363
-
P0163 : Monitoring heart rate variability during acute decompensation predicts mortality and potential risk of recurrent hospitalisationSawhney, R. / Chatterjee, D. A. / Leon, A. G. / Jalan, R. / Mookerjee, R. P. et al. | 2015
- S366
-
P0170 : Effects of nutritional therapy on cognitive functions and health related quality of life in patients of liver cirrhosis with minimal hepatic encephalopathy - an open label randomized controlled trialMaharshi, S. / Chander Sharma, B. / Srivastava, S. et al. | 2015
- S367
-
P0173 : Predictors of mortality in cirrhotic patients admitted to intensive care unit: Comparison of different scoring systems including the new Royal Free Hospital scoreNaksuk, N. / Peeraphatdit, T. / Thongprayoon, C. / Roberts, L. R. / Chaiteerakij, R. et al. | 2015
- S368
-
P0175 : Assessment of serum glycomics (glycocirrhotest) for risk prediction of hepatocellular carcinoma development in patients with cirrhosisVerhelst, X. / Vanderschaeghe, D. / Castera, L. / Geerts, A. / Goutte, N. / Francoz, C. / Durand, F. / Callewaert, N. / Van Vlierberghe, H. et al. | 2015
- S369
-
P0177 : A simple operative criterion to assess patients with low grade of hepatic encephalopathyCampagna, F. / Montagnese, S. / Ridola, L. / Schiff, S. / Aprile, D. / Testa, G. / De Rui, M. / Senzolo, M. / Nardelli, S. / Pentassuglio, I. et al. | 2015
- S370
-
P0179 : The model for critically ill cirrhotics (MCIC): a novel prognostic score for predicting mortality in critically ILL cirrhotics admitted to ICUSahney, A. / Choudhary, A. / Abby, C. P. / Sinha, A. K. / Vyas, T. / Maiwall, R. / Sharma, M. / Mitra, L. / Saluja, V. / Premkumar, M. et al. | 2015
- S371
-
P0181 : Development and validation of a mathematical formula to estimate GFR in patients with cirrhosisKalafateli, M. / Burniston, M. / Wickham, C. / Theocharidou, E. / Arora, S. / Burroughs, A. K. / Tsochatzis, E. et al. | 2015
- S372
-
P0184 : Hepatopulmonary syndrome is not associated with higher rates of left ventricle diastolic dysfunction in patients with cirrhosisVoiosu, A. / Daha, I. / Voiosu, T. / Diculescu, M. et al. | 2015
- S373
-
P0186 : A Model to predict mortality in cirrhotics presenting with cellulitisPhilips, C. A. / Prabhat, R. / Sahney, A. / Anand, L. / Rangegowda, D. / Kumar, A. / Kumar, G. / Bhatia, V. / Sarin, S. K. et al. | 2015
- S377
-
P0194 : Severe 25-hydroxyvitamin D deficiency is associated with infections and mortality in cirrhosisFinkelmeier, F. / Kronenberger, B. / Zeuzem, S. / Piiper, A. / Waidmann, O. et al. | 2015
- S378
-
P0196 : Nutritional status evaluation of nonhospitalized patients with alcoholic liver cirrhosisGiestas, S. / Giestas, A. / Agostinho, C. / Sofia, C. et al. | 2015
- S379
-
P0198 : Percentage change in serum creatinine (SCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1)on behalf, o. T. / Boyer, T. D. / Sanyal, A. J. / Pappas, S. C. / Wong, F. / Jamil, K. et al. | 2015
- S381
-
P0203 : Solute-free water retention in experimental ascitic cirrhosis: Vasopressin (ADH) is not the only agent to blameSansoe, G. / Aragno, M. / Mastrocola, R. / Parola, M. et al. | 2015
- S382
-
P0205 : Management of gastric varices: A french national surveyClub, F. p. / Weil, D. / Cervoni, J. P. / Fares, N. / Rudler, M. / Bureau, C. / Plessier, A. / Dao, T. / Pauwels, A. / Thabut, D. et al. | 2015
- S383
-
P0208 : Hemodynamic response to non-selective beta-blockers is not influenced by the presence of metabolic syndromeBota, S. / Schwabl, P. / Mandorfer, M. / Salzl, P. / Schwarzer, R. / Ferlitsch, A. / Trauner, M. / Peck-Radosavljevic, M. / Reiberger, T. et al. | 2015
- S384
-
P0211 : Human microfibril-associated protein 4 (MFAP4) in ascites fluid predicts survival and risk of complications in patients with advanced cirrhosisKjaergaard, M. / Madsen, B. S. / Thiele, M. / Malchow-Moller, A. / Schlosser, A. / Sorensen, G. L. / Holmskov, U. / Krag, A. et al. | 2015
- S386
-
P0215 : Metformin reduces hyperammonemia in portacaval shunted rats inhibiting glutaminase activityGil-Gomez, A. / Ranchal, I. / Gomez-Sotelo, A. I. / Ampuero, J. / Garcia-Valdecasas, M. / Rojas, A. / Gallego-Duran, R. / Del Campo, J. A. / Romero-Gomez, M. et al. | 2015
- S387
-
P0217 : Use of beta-blockers at the onset of spontaneous bacterial peritonitis may be beneficial due to modulation of immune responseLutz, P. / Nischalke, H. D. / Kraemer, B. / Langhans, B. / Schlabe, S. / Nattermann, J. / Hoerauf, A. / Strassburg, C. P. / Spengler, U. et al. | 2015
- S390
-
P0223 : Role of ARL6IP5 in HCV-related hepatocellular carcinomaHu, Z. / Wilson, G. S. / George, J. / Qiao, L. et al. | 2015
- S391
-
P0225 : Combination of CD40L co-stimulation with alpha-fetoprotein pulsed dendritic cells induced an early and strong TH1-shift in the tumor environment and synergistic antitumoral effects in subcutaneous and orthotopic murine hepatocellular carcinoma modelVogt, A. / Schneider, C. / Ayub, T. H. / Decker, G. / Prieto, J. / Conchon, S. / Schmidt-Wolf, I. G. / Strassburg, C. P. / Gonzalez-Carmona, M. A. et al. | 2015
- S393
-
P0231 : Effect of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma generated by hydrodynamic injectionKim, M. N. / Ro, S. W. / Kim, D. Y. / Park, J. H. / Lim, H. Y. / Han, K. H. et al. | 2015
- S394
-
P0234 : A TGF-beta genomic signature in intrahepatic cholangiocarcinoma highlights a novel long non coding RNA located in the nuclear paraspeckles of tumor cholangiocytesMerdrignac, A. / Angenard, G. / Bergeat, D. / Fautrel, A. / Turlin, B. / Boudjema, K. / Clement, B. / Sulpice, L. / Coulouarn, C. et al. | 2015
- S395
-
P0237 : Hepatocellular carcinoma: Applied genomics to diagnostic and personalized therapyLlerena, S. / Garcia, N. / Rodriguez de Lope, C. / Cereceda, L. / Martin, L. / Lopez, C. / Cagigas, C. / Castillo, F. / Azueta, A. / Piris, M. A. et al. | 2015
- S397
-
P0243 : Role of S100A8/A9 in carcinogen-induced hepatocellular carcinoma onset and developmentDe Ponti, A. / Schneller, D. / Pusterla, T. / Wiechert, L. / Longerich, T. / Vogel, A. / Hess, J. / Angel, P. et al. | 2015
- S400
-
P0252 : Identification of the apical sodium bile salt transporter (ASBT) as a novel molecular target to enhance the sensitivity of cholangiocarcinoma to chemotherapyLozano, E. / Macias, R. I. / Monte, M. J. / Briz, O. / Jimenez, F. / Jimenez, S. / Castano, B. / Al-Abdulla, R. / Al-Aqil, F. / Hernandez, A. et al. | 2015
- S401
-
P0255 : Disruption of the GP130 signaling pathway in hepatocytes attenuates hepatocarcinogenesisCubero, F. J. / Hatting, M. / Spannbauer, M. / Peng, J. / Al Masaoudi, M. / Sellge, G. / Nevzorova, Y. A. / Gassler, N. / Liedtke, C. / Trautwein, C. et al. | 2015
- S402
-
P0258 : Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposureVandewynckel, Y. P. / Laukens, D. / Devisscher, L. / Paridaens, A. / Bogaerts, E. / Verhelst, X. / Van den Bussche, A. / Raevens, S. / Van Steenkiste, C. / Van Troys, M. et al. | 2015
- S404
-
P0262 : Inhibition of regulatory T cells using the FOXP3-inhibitory peptide P60 improves antitumoural effect of a vaccination with mAFP-expressing DC in subcutaneous and orthotopic murine HCC modelWaysczak, J. / Vogt, A. / Casares, N. / Lasarte, J. J. / Prieto, J. / Schmidt-Wolf, I. / Strassburg, C. P. / Gonzalez-Carmona, M. A. et al. | 2015
- S405
-
P0265 : IGF2 is an oncogenic driver in HCC and emerges as a potential target for therapiesMartinez-Quetglas, I. / Pinyol, R. / Dauch, D. / Portela, A. / Peix, J. / Higuera, M. / Zucman-Rossi, J. / Esteller, M. / Mazzaferro, V. / Zender, L. et al. | 2015
- S407
-
P0270 : SerpinB3 and Yap interplay increases Myc oncogenic activityTurato, C. / Cannito, S. / Simonato, D. / Gianmarco, V. / Terrin, L. / Quarta, S. / Biasiolo, A. / Ruvoletto, M. / Fasolato, S. / Zanus, G. et al. | 2015
- S409
-
P0274 : Liver tumor incidence is dependent on sex and telomerase status in Trp53 knockout miceSvinarenko, M. / Katz, S. F. / Seufferlein, T. / Schirmacher, P. / Lechel, A. et al. | 2015
- S412
-
P0281 : Decellularised human liver as a natural scaffold for 3D-disease modellingMazza, G. / Al-Akkad, W. / Telese, A. / Longato, L. / Hall, A. / Urbani, L. / Fuller, B. / Davidson, B. / Malago', M. / Moore, K. et al. | 2015
- S413
-
P0282 : The long non coding RNA UC.158 modulates growth of Wnt/b;-catenin driven hepatocellular carcinoma (HCC)Cheong, I. H. / Lampis, A. / Fassan, M. / Paulus-Hock, V. / Vicentini, C. / Hahne, J. / Cascione, L. / Quagliata, L. / Jamieson, T. / Athineos, D. et al. | 2015
- S414
-
P0285 : Inactivation of cyclin E1 acts pro-apoptotic and anti-proliferative in primary hepatoma cells and protects from hepatocarcinogenesis in miceSonntag, R. / Moro, N. / Nevzorova, Y. A. / Bangen, J. M. / Fahrenkamp, D. / Lambertz, D. / Hu, W. / Gassler, N. / Muller-Newen, G. / Weiskirchen, R. et al. | 2015
- S415
-
P0286 : C-MET signaling contributes to carcinogenesis of cholangiocarcinoma and is blocked by LY2801653, a small molecule inhibitorBarat, S. / Bozko, P. / Chen, X. / Scholta, T. / Hanert, F. / Gotze, J. / Malek, N. / Wilkens, L. / Plentz, R. et al. | 2015
- S417
-
P0292 : Knockdown of NANOG reverses the chemoresistance to doxorubicin in liver cancer stem-like cells by reducing ABCB1 and ABCG2 expressionZhou, J. / Chen, R. / Deng, X. et al. | 2015
- S418
-
P0294 : Oncogenesis: A potential ''off-target'' effect of radiofrequency ablationRozenblum, N. / Zeira, E. / Scaiewicz, V. / Bulvik, B. / Gourevitch, S. / Galun, E. / Goldberg, N. S. et al. | 2015
- S419
-
P0297 : The transforming growth factor-beta (TGF-b) governs human liver tumor cell plasticityMalfettone, A. / Fernando, J. / Koudelkova, P. / Soukupova, J. / Bertran, E. / Fabra, A. / Grubinger, M. / Rani, B. / Giannelli, G. / Mikulits, W. et al. | 2015
- S420
-
P0299 : Sorafenib effect on mitochondrial function provides a target for increasing HCC therapy efficacyTutusaus, A. / Stefanovic, M. / Fernandez-Checa, J. C. / Mari, M. / Morales, A. et al. | 2015
- S421
-
P0302 : Constitutive gp130 activation accelerates transformation of proliferating human hepatocytes via increased levels of oxidative stressGil-Ibanez, I. / Heim, D. / Herden, J. / Parplys, A. C. / Borgmann, K. / Schmidt-Arras, D. / Lohse, A. W. / Rose-John, S. / Wege, H. et al. | 2015
- S422
-
P0304 : Three dimensional culture of HepG2 liver cells on a rat decellularized liver matrix as a model for hepatocellular carcinoma patientsHussein, K. / Park, K. M. / Hoon, G. J. / Yang, S. R. / Woo, H. M. et al. | 2015
- S424
-
P0309 : Gene expression profiling of hepatocellular carcinoma biopsies reveals three molecular classes with distinct clinical and biological propertiesMakowska, Z. / Boldanova, T. / Adametz, D. / Quagliata, L. / Vogt, J. E. / Dill, M. T. / Matter, M. S. / Roth, V. / Terracciano, L. / Heim, M. H. et al. | 2015
- S425
-
P0311 : Balb/c and C57/Bl6 mice exhibit differences in their susceptibility and anti-tumor response to B16F10 melanoma liver metastasisFoerster, F. / Strobl, S. / Kaps, L. / Weng, S. Y. / Kim, Y. O. / Bros, M. / Diken, M. / Boegel, S. / Castle, J. / Bockamp, E. et al. | 2015
- S426
-
P0314 : Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5P in hepatocellular carcinomaIuliu, H. T. / Vedean, M. et al. | 2015
- S429
-
P0322 : Glypican-3 promotes hepatocellular carcinoma progression and metastasis by activation of the ERK signaling pathwayWu, Y. / Liu, H. / Weng, H. / Zhang, X. / Li, P. / Fan, C. / Li, B. / Dong, P. / Li, L. / Dooley, S. et al. | 2015
- S430
-
P0325 : Every 3-month surveillance is superior to semiannual surveillance for the survival of patients with hepatocellular carcinoma after hepatectomy: A 10-year observational studyLee, M. / Oh, S. / Cho, Y. Y. / Yoo, J. J. / Cho, Y. / Lee, D. H. / Cho, E. J. / Lee, J. H. / Yu, S. J. / Yi, N. J. et al. | 2015
- S431
-
P0327 : Analysis of hepatic progenitor cell marker positive hepatocellular carcinoma and their prognostic significanceTsuchiya, A. / Kojima, Y. / Seino, S. / Watanabe, Y. / Nomoto, M. / Forbes, S. J. / Terai, S. et al. | 2015
- S435
-
P0335 : Serum long chain ceramides, sphingosine and sphingosine-1-phosphate as novel diagnostic markers in patients with hepatocellular carcinomaGrammatikos, G. / Schoell, N. / Ferreiros, N. / Bon, D. / Herrmann, E. / Farnik, H. / Zeuzem, S. / Kronenberger, B. / Waidmann, O. / Pfeilschifter, J. et al. | 2015
- S436
-
P0338 : Survival post sorafenib in hepatocellular carcinoma: Are AFP non-secretors a distinct sub-group?Afshar, M. / Clarke, H. / Jackson-Wilding, A. / Ahmed, A. / Ma, Y. T. / Punia, P. et al. | 2015
- S437
-
P0341 : Decreasing mortality by liver diseases but increasing incidence of and mortality by hepatocellular carcinoma in a hepatitis B virus endemic area: Nationwide whole population data analysesLim, Y. S. / Chang, Y. / An, J. / Kim, N. et al. | 2015
- S438
-
P0343 : The pattern of alpha-fetoprotein level has greater diagnostic value compared to isolated values in predicting the presence of hepatocellular carcinomaVasudevan, A. / Lubel, J. / Denyar, N. / Nalankilli, K. / Jackson, A. / Greenhalgh, J. / Scanlon, C. et al. | 2015
- S441
-
P0351 : Highly sensitive a-fetoprotein, Lens culinaris agglutinin-reactive fraction of a-fetoprotein and des-g-carboxy prothrombin for hepatocellular carcinoma detection in an Italian cohortAbate, M. L. / Caviglia, G. P. / Petrini, E. / Gaia, S. / Carucci, P. / Smedile, A. et al. | 2015
- S443
-
P0355 : The evaluation of an automated recall programme for surveillance liver ultrasound in patients at increased risk of hepatocellular carcinomaThe, L. C. / Farrell, C. / Cross, T. J. / Halpen, A. / Richardson, P. D. / Healey, P. / Barr, J. / Ladep, N. / Noorullah, O. / Sturgess, R. P. et al. | 2015
- S445
-
P0360 : STAT6 rs3024974 might predict worse prognosis in hepatocellular carcinoma patientsLiao, Y. / Cai, B. / Li, Y. / Wang, L. et al. | 2015
- S446
-
P0362 : Hepatocellular carcinoma incidence in chronic hepatitis C patients according to antiviral treatment statusPurevsambuu, T. / Bota, S. / Hucke, F. / Hofer, H. / Ferenci, P. / Sieghart, W. / Peck-Radosavljevic, M. et al. | 2015
- S447
-
P0364 : Clinic evaluation of circulating micrornas as potential biomarkers of hepatocellular carcinoma in patients with HBV chronic infectionCaviglia, G. P. / Abate, M. L. / Petrini, E. / Gaia, S. / Manzini, P. / Carucci, P. / Rizzetto, M. / Smedile, A. et al. | 2015
- S449
-
P0368 : Long term survival after repeat liver resection for colorectal liver metastasis is possibleConte, G. / Trochsler, M. / Maddern, G. et al. | 2015
- S451
-
P0372 : Gideon: A retrospective analysis of prognostic factors for survivalBronowicki, J. P. / Kudo, M. / Lencioni, R. / Chen, X. P. / Dagher, L. / Furuse, J. / Geschwind, J. F. / Ladron de Guevara, L. / Papandreou, C. / Sanyal, A. J. et al. | 2015
- S452
-
P0375 : The validation of Hong Kong Liver Cancer staging system and comparision with Barcelona Clinic Liver Cancer for prediction of survival and treatment in hepatocellular carcinoma patientsKim, H. R. / Kim, J. H. / Yoo, Y. J. / Kang, S. H. / Lee, Y. S. / Suh, S. J. / Jung, Y. K. / Seo, Y. S. / Yim, H. J. / Yeon, J. E. et al. | 2015
- S453
-
P0377 : Tumor number improves the prognostic value of hepatoma arterial-embolization score in patients with hepatocellular carcinoma treated with chemoembolizationPark, Y. / Kim, S. U. / Kim, B. K. / Park, J. Y. / Kim, D. Y. / Ahn, S. H. / Park, Y. E. / Park, J. H. / Lee, Y. I. / Yun, H. R. et al. | 2015
- S454
-
P0380 : New recognization of the natural history and growth pattern of hepatic hemangioma in adultsLi, J. / Yan, Y. / Huang, L. / Liu, C. / Yan, J. / Xu, F. et al. | 2015
- S455
-
P0382 : Angiotensin II type 1 receptor antagonists as adjuvant therapy for hepatocellular carcinoma patients treated with radiofrequency ablationFacciorusso, A. / Del Prete, V. / Crucinio, N. / Di Leo, A. / Barone, M. et al. | 2015
- S459
-
P0390 : Baseline bilirubin and not Child-Pugh a or B7 predicts survival of BCLC B patients treated with sorafenib. The clinical approach to the stratification debateGazzola, A. / Di Donato, R. / Reig, M. / Llarch, N. / Forner, A. / Darnell, A. / Rimola, J. / Ayuso, C. / Bruix, J. et al. | 2015
- S460
-
P0393 : Self-assembled liver organoids recapitulate hepato-biliary organogenesis in vitroBaptista, P. M. / Vyas, D. / Moran, E. / Atala, A. / Reid, L. / Soker, S. et al. | 2015
- S463
-
P0400 : Microrna signature of early-stage hepatocellular carcinoma arising in HCV-related cirrhosisGhittoni, G. / Veronese, L. / Torello Viera, F. / Curti, V. / Ghitti, M. / Rosa, L. L. / Ravetta, V. / Siciliani, L. / Rossi, S. et al. | 2015
- S464
-
P0403 : Steatotic liver as a source of hepatic progenitor cells with therapeutic potentialLu, W. Y. / Tsuchiya, A. / Boulter, L. / Guest, R. / Wojtacha, D. / Bird, T. / Man, T. Y. / Hay, D. / Iredale, J. / Forbes, S. et al. | 2015
- S465
-
P0406 : Deletion of Cdk1 in the liver induces changes in pyruvate metabolismCaldez, M. / Teo, X. Q. / Van Hul, N. / Lee, P. / Kaldis, P. et al. | 2015
- S467
-
P0411 : Pregnancy induces selective changes in hepatic genes involved in cell proliferation and apoptosis in miceGrenfell, L. / Hanson, M. / Lillycrop, K. / Burdge, G. et al. | 2015
- S468
-
P0414 : Constitutive androstane receptor-mediated down-regulation of miR-122 in liverPustylnyak, Y. A. / Kazantseva, Y. A. / Yarushkin, A. A. / Tulupov, A. A. / Pustylnyak, V. O. et al. | 2015
- S469
-
P0416 : Relevance of BMP9-mediated signaling in oval cell function during liver injury. Crosstalk with the HGF/Met pathwayAddante, A. / Garcia-Alvaro, M. / Roncero, C. / Almale, L. / Deleyto, N. / Fernandez, M. / Fabregat, I. / Herrera, B. / Sanchez, A. et al. | 2015
- S470
-
P0419 : In vivo cell specific gene silencing in the liver using novel siRNA-loaded nanohydrogel particlesAG Prof, D. D. / Kaps, L. / Nuhn, L. / Foerster, F. / Brose, A. / Heck, R. / Diken, M. / Zentel, R. / Schuppan, D. et al. | 2015
- S472
-
P0426 : Inhibition of monoacylglycerol lipase accelerates liver fibrosis regressionHabib, A. / Wan, J. / Hedge, P. / Weiss, E. / Brouillet, A. / Lodder, J. / Moreau, R. / Lotersztajn, S. et al. | 2015
- S473
-
P0429 : Deletion of TIMP-1 (exon 3) does not affect hepatic fibrogenesis and carcinogenesisGuenther, N. D. / Lohse, A. / Kluwe, J. et al. | 2015
- S475
-
P0434 : JNK1-dependent ER stress contributes to hepatic stellate cell activationThoen, L. F. / Mannaerts, I. / Cubero, F. J. / Paridaens, A. / Colle, I. / Trautwein, C. / van Grunsven, L. A. et al. | 2015
- S476
-
P0436 : Pentraxin-3 induces hepatic stellate cell activation and attenuates the inflammatory response during hepatic injuryPerea, L. / Coll, M. / El Taghdouini, A. / Rodrigo-Torres, D. / Blaya, D. / Morales-Ibanez, O. / Llopis, M. / Van Grunsven, L. / Caballeria, J. / Gines, P. et al. | 2015
- S477
-
P0440 : Antifibrotic efficacy of TGF-beta receptor antagonist in precision-cut human and rat liver slicesLuangmonkong, T. / Mutsaers, R. / Oosterhuis, D. / Olinga, P. et al. | 2015
- S478
-
P0443 : Hyperammonemia activates human hepatic stellate cells and is a target for treatment of portal hypertensionDe Chiara, F. / Jalan, R. / Balasubramaniyan, V. / Andreola, F. / Malago', M. / Pinzani, M. / Mookerjee, R. P. / Rombouts, K. et al. | 2015
- S482
-
P0454 : An additional heme oxygenase-1 knockout increases maturation of dendritic cells and liver inflammation in Mdr2 knockout miceBarikbin, R. / Sandmann, M. / Quaas, A. / Karimi, K. / Sass, G. / Tiegs, G. et al. | 2015
- S483
-
P0457 : Graphene quantum dots attenuate concanavalin A-induced hepatitisVolarevic, V. / Paunovic, V. / Markovic, Z. / Simovic Markovic, B. / Misirkic Marjanovic, M. / Todorovic Markovic, B. / Bojic, S. / Vucicevic, L. / Jovanovic, S. / Arsenijevic, N. et al. | 2015